CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: camptothecin
Accession: CHEBI:27656
browse the term
Definition: A pyranoindolizinoquinoline that is pyrano[3',4':6,7]indolizino[1,2-b]quinoline which is substituted by oxo groups at positions 3 and 14, and by an ethyl group and a hydroxy group at position 4 (the S enantiomer).
Synonyms: exact_synonym: (4S)-4-ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
related_synonym: (S)-(+)-camptothecin; 20(S)-camptothecine; 21,22-Secocamptothecin-21-oic acid lactone; CPT; Camptothecine; D-camptothecin; Formula=C20H16N2O4; InChI=1S/C20H16N2O4/c1-2-20(25)14-8-16-17-12(7-11-5-3-4-6-15(11)21-17)9-22(16)18(23)13(14)10-26-19(20)24/h3-8,25H,2,9-10H2,1H3/t20-/m0/s1; InChIKey=VSJKWCGYPAHWDS-FQEVSTJZSA-N; SMILES=CC[C@@]1(O)C(=O)OCc2c1cc1-c3nc4ccccc4cc3Cn1c2=O
alt_id: CHEBI:22997; CHEBI:3343
xref: CAS:7689-03-4; DrugBank:DB04690; KEGG:C01897; KNApSAcK:C00002145; LINCS:LSM-4611
xref_mesh: MESH:D002166
xref: PDBeChem:EHD; PMID:11024478; PMID:11549373; PMID:23344961; PMID:23474217; PMID:23676007; PMID:8965250; Reaxys:6075662; Wikipedia:Camptothecin
G
Abcb1a
ATP binding cassette subfamily B member 1A
decreases expression multiple interactions
ISO
Camptothecin results in decreased expression of ABCB1 mRNA; Camptothecin results in decreased expression of ABCB1 protein Camptothecin inhibits the reaction [Rifampin results in increased expression of ABCB1 mRNA]
CTD
PMID:10692111 PMID:29356861
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcc1
ATP binding cassette subfamily C member 1
decreases response to substance multiple interactions
ISO
ABCC1 protein results in decreased susceptibility to Camptothecin analog Camptothecin inhibits the reaction [ABCC1 results in decreased susceptibility to Daunorubicin]
CTD
PMID:11778547 PMID:12115804
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
G
Abcg4
ATP binding cassette subfamily G member 4
increases expression
ISO
Camptothecin results in increased expression of ABCG4 mRNA
CTD
PMID:38460933
NCBI chr 8:44,611,187...44,629,818
Ensembl chr 8:44,611,187...44,626,881
G
Acer2
alkaline ceramidase 2
increases expression
ISO
Camptothecin results in increased expression of ACER2 mRNA
CTD
PMID:38460933
NCBI chr 5:101,391,830...101,442,615
Ensembl chr 5:101,391,885...101,442,614
G
Ache
acetylcholinesterase
increases expression
ISO
Camptothecin results in increased expression of ACHE mRNA
CTD
PMID:38460933
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
G
Acta2
actin alpha 2, smooth muscle
increases expression
ISO
Camptothecin results in increased expression of ACTA2 mRNA
CTD
PMID:38460933
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
G
Acvr1b
activin A receptor type 1B
increases methylation
ISO
Camptothecin results in increased methylation of ACVR1B gene
CTD
PMID:30720231
NCBI chr 7:132,286,266...132,329,679
Ensembl chr 7:132,286,275...132,329,673
G
Adam19
ADAM metallopeptidase domain 19
decreases response to substance
ISO
ADAM19 mRNA results in decreased susceptibility to Camptothecin
CTD
PMID:25269479
NCBI chr10:30,491,362...30,583,115
Ensembl chr10:30,491,405...30,583,105
G
Adamts7
ADAM metallopeptidase with thrombospondin type 1 motif, 7
increases expression
ISO
Camptothecin results in increased expression of ADAMTS7 mRNA
CTD
PMID:38460933
NCBI chr 8:90,704,727...90,744,333
Ensembl chr 8:90,704,727...90,744,328
G
Adrb2
adrenoceptor beta 2
increases expression
ISO
Camptothecin results in increased expression of ADRB2 mRNA
CTD
PMID:38460933
NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
G
Agap1
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1
increases methylation
ISO
Camptothecin results in increased methylation of AGAP1 gene
CTD
PMID:30720231
NCBI chr 9:90,039,720...90,475,196
Ensembl chr 9:90,039,605...90,470,958
G
Agrn
agrin
increases expression
ISO
Camptothecin results in increased expression of AGRN mRNA
CTD
PMID:17374387
NCBI chr 5:166,749,306...166,782,212
Ensembl chr 5:166,749,310...166,786,003
G
Agrp
agouti related neuropeptide
decreases response to substance
ISO
AGRP mRNA results in decreased susceptibility to Camptothecin
CTD
PMID:25269479
NCBI chr19:33,447,992...33,481,602
Ensembl chr19:33,447,992...33,449,584
G
Aifm3
AIF family member 3
decreases response to substance
ISO
AIFM3 mRNA results in decreased susceptibility to Camptothecin
CTD
PMID:25269479
NCBI chr11:83,504,859...83,523,630
Ensembl chr11:83,504,861...83,521,248
G
Akap13
A-kinase anchoring protein 13
decreases response to substance
ISO
AKAP13 mRNA results in decreased susceptibility to Camptothecin
CTD
PMID:25269479
NCBI chr 1:129,313,183...129,619,647
Ensembl chr 1:129,314,402...129,619,646
G
Akap8
A-kinase anchoring protein 8
increases expression
ISO
Camptothecin results in increased expression of AKAP8 mRNA
CTD
PMID:33770205
NCBI chr 7:11,316,224...11,332,523
Ensembl chr 7:11,316,228...11,332,399
G
Akt1
AKT serine/threonine kinase 1
affects phosphorylation multiple interactions increases phosphorylation
ISO
Camptothecin affects the phosphorylation of AKT1 protein 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Camptothecin results in increased phosphorylation of AKT1 protein]; Camptothecin results in decreased expression of and results in decreased phosphorylation of AKT1 protein; Diethylhexyl Phthalate inhibits the reaction [Camptothecin results in decreased phosphorylation of AKT1 protein]; Nicotine affects the reaction [Camptothecin affects the phosphorylation of AKT1 protein]; Wortmannin inhibits the reaction [Camptothecin results in increased phosphorylation of AKT1 protein]
CTD
PMID:24095863 PMID:30851366 PMID:36394428
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Alb
albumin
affects binding multiple interactions
ISO
Camptothecin analog binds to ALB protein; Camptothecin binds to ALB protein CTSB protein results in increased cleavage of [Camptothecin analog binds to ALB protein]
CTD
PMID:10803926 PMID:17378599
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Aldh1l1
aldehyde dehydrogenase 1 family, member L1
increases expression
ISO
Camptothecin results in increased expression of ALDH1L1 mRNA
CTD
PMID:38460933
NCBI chr 4:123,059,989...123,106,471
Ensembl chr 4:123,060,008...123,106,465
G
Alms1
ALMS1, centrosome and basal body associated protein
decreases methylation
ISO
Camptothecin results in decreased methylation of ALMS1 gene
CTD
PMID:30720231
NCBI chr 4:118,125,581...118,226,005
Ensembl chr 4:118,125,607...118,226,005
G
Alox12b
arachidonate 12-lipoxygenase, 12R type
increases expression
ISO
Camptothecin results in increased expression of ALOX12B mRNA
CTD
PMID:38460933
NCBI chr10:53,863,060...53,874,938
Ensembl chr10:53,863,060...53,874,938
G
Aloxe3
arachidonate epidermal lipoxygenase 3
increases expression
ISO
Camptothecin results in increased expression of ALOXE3 mRNA
CTD
PMID:38460933
NCBI chr10:53,830,219...53,854,328
Ensembl chr10:53,831,264...53,854,328
G
Als2cl
ALS2 C-terminal like
increases expression
ISO
Camptothecin results in increased expression of ALS2CL mRNA
CTD
PMID:38460933
NCBI chr 8:110,863,753...110,884,434
Ensembl chr 8:110,864,975...110,884,419
G
Andpro
androgen regulated protein
increases expression
ISO
Camptothecin results in increased expression of CST4 mRNA
CTD
PMID:38460933
NCBI chr 3:136,718,601...136,725,131
Ensembl chr 3:136,718,602...136,724,966
G
Ankra2
ankyrin repeat family A member 2
increases expression
ISO
Camptothecin results in increased expression of ANKRA2 mRNA
CTD
PMID:38460933
NCBI chr 2:29,612,867...29,623,748
Ensembl chr 2:29,612,925...29,623,730
G
Anxa4
annexin A4
increases expression
ISO
Camptothecin results in increased expression of ANXA4 mRNA
CTD
PMID:17374387
NCBI chr 4:119,184,378...119,241,183
Ensembl chr 4:119,184,374...119,241,161
G
Aox1
aldehyde oxidase 1
increases expression
ISO
Camptothecin results in increased expression of AOX1 mRNA
CTD
PMID:38460933
NCBI chr 9:59,579,621...59,658,772
Ensembl chr 9:59,579,649...59,658,770
G
Apc
APC regulator of WNT signaling pathway
increases methylation
ISO
Camptothecin results in increased methylation of APC gene
CTD
PMID:30720231
NCBI chr18:25,828,558...25,925,511
Ensembl chr18:25,864,222...25,922,696
G
Apod
apolipoprotein D
increases expression
ISO
Camptothecin results in increased expression of APOD mRNA
CTD
PMID:38460933
NCBI chr11:69,431,261...69,452,306
Ensembl chr11:69,431,260...69,452,305
G
Aqp11
aquaporin 11
increases expression
ISO
Camptothecin results in increased expression of AQP11 mRNA
CTD
PMID:38460933
NCBI chr 1:152,046,515...152,056,675
Ensembl chr 1:152,046,517...152,056,725
G
Aqp3
aquaporin 3 (Gill blood group)
increases expression
ISO
Camptothecin results in increased expression of AQP3 mRNA
CTD
PMID:38460933
NCBI chr 5:56,239,200...56,244,718
Ensembl chr 5:56,239,201...56,244,720
G
Ar
androgen receptor
multiple interactions
ISO
Camptothecin binds to and results in decreased activity of AR protein
CTD
PMID:25752796
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Arc
activity-regulated cytoskeleton-associated protein
increases expression
ISO
Camptothecin results in increased expression of ARC mRNA
CTD
PMID:38460933
NCBI chr 7:106,555,968...106,559,697
Ensembl chr 7:106,555,785...106,559,378
G
Arl14
ARF like GTPase 14
increases expression
ISO
Camptothecin results in increased expression of ARL14 mRNA
CTD
PMID:38460933
NCBI chr 2:153,468,863...153,470,102
Ensembl chr 2:153,468,977...153,469,555
G
Armcx1
armadillo repeat containing, X-linked 1
increases expression
ISO
Camptothecin results in increased expression of ARMCX1 mRNA
CTD
PMID:38460933
NCBI chr X:97,898,969...97,902,874
Ensembl chr X:97,898,883...97,903,299
G
Artn
artemin
decreases response to substance
ISO
ARTN mRNA results in decreased susceptibility to Camptothecin
CTD
PMID:25269479
NCBI chr 5:131,458,596...131,470,193
Ensembl chr 5:131,464,756...131,468,025
G
Arvcf
ARVCF, delta catenin family member
increases expression
ISO
Camptothecin results in increased expression of ARVCF mRNA
CTD
PMID:38460933
NCBI chr11:82,588,137...82,645,832
Ensembl chr11:82,587,881...82,645,805
G
Arx
aristaless related homeobox
increases expression
ISO
Camptothecin results in increased expression of ARX mRNA
CTD
PMID:38460933
NCBI chr X:58,016,233...58,028,149
Ensembl chr X:58,016,233...58,028,142
G
Ass1
argininosuccinate synthase 1
increases expression
ISO
Camptothecin results in increased expression of ASS1 mRNA
CTD
PMID:38460933
NCBI chr 3:14,747,355...14,796,909
Ensembl chr 3:14,747,368...14,796,903
G
Atf4
activating transcription factor 4
multiple interactions increases expression
ISO
Glutathione inhibits the reaction [Camptothecin results in increased expression of ATF4 protein]; MYC protein affects the reaction [Camptothecin results in increased expression of ATF4 protein]
CTD
PMID:30266318
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
G
Atg5
autophagy related 5
multiple interactions
ISO
ATG5 mutant form inhibits the reaction [Camptothecin results in increased degradation of SQSTM1 protein]
CTD
PMID:22927544
NCBI chr20:47,798,217...47,889,216
Ensembl chr20:47,798,290...47,889,209
G
Atg7
autophagy related 7
multiple interactions increases expression
ISO
Egtazic Acid inhibits the reaction [Camptothecin results in increased expression of ATG7 protein]; EIF2S1 protein affects the reaction [Camptothecin results in increased expression of ATG7 protein]; staurosporine aglycone inhibits the reaction [Camptothecin results in increased expression of ATG7 protein]
CTD
PMID:30266318
NCBI chr 4:147,718,663...147,925,656
Ensembl chr 4:147,718,752...147,925,593
G
Atm
ATM serine/threonine kinase
decreases expression multiple interactions increases expression increases activity
ISO EXP
Camptothecin results in decreased expression of ATM mRNA Diethylhexyl Phthalate inhibits the reaction [Camptothecin results in increased expression of ATM protein modified form]; ESR1 promotes the reaction [Diethylhexyl Phthalate inhibits the reaction [Camptothecin results in increased expression of ATM protein modified form]] camptothecin increases kinase activity in rat cerebellar granule neurons
CTD RGD
PMID:24792648 PMID:30720231 PMID:19151707
RGD:10053571
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
G
Atosa
atos homolog A
increases expression
ISO
Camptothecin results in increased expression of FAM214A mRNA
CTD
PMID:38460933
NCBI chr 8:75,694,828...75,772,565
Ensembl chr 8:75,695,022...75,772,549
G
Atr
ATR serine/threonine kinase
decreases response to substance multiple interactions increases phosphorylation
ISO
ATR mRNA results in decreased susceptibility to Camptothecin; ATR protein results in decreased susceptibility to Camptothecin 3-amino-6-(4-(methylsulfonyl)phenyl)-N-phenylpyrazine-2-carboxamide inhibits the reaction [Camptothecin results in increased phosphorylation of ATR protein]
CTD
PMID:25269479 PMID:30555576
NCBI chr 8:96,426,704...96,524,152
Ensembl chr 8:96,426,724...96,524,136
G
B3gnt7
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7
increases expression
ISO
Camptothecin results in increased expression of B3GNT7 mRNA
CTD
PMID:38460933
NCBI chr 9:86,956,220...86,960,171
Ensembl chr 9:86,956,220...86,960,170
G
Bak1
BCL2-antagonist/killer 1
multiple interactions decreases expression
ISO
Folic Acid inhibits the reaction [Camptothecin results in decreased expression of BAK1 mRNA]
CTD
PMID:30581319
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
G
Batf2
basic leucine zipper ATF-like transcription factor 2
increases expression
ISO
Camptothecin results in increased expression of BATF2 mRNA
CTD
PMID:38460933
NCBI chr 1:203,467,291...203,479,428
Ensembl chr 1:203,468,097...203,475,889
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions increases activity increases expression decreases expression
ISO EXP
[Camptothecin co-treated with 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole] results in decreased expression of BAX protein; Camptothecin affects the cleavage of and results in decreased expression of BAX protein; Folic Acid inhibits the reaction [Camptothecin results in decreased expression of BAX mRNA] Camptothecin results in increased activity of BAX protein Camptothecin results in increased expression of BAX protein pifithrin inhibits the reaction [Camptothecin results in increased expression of BAX protein] Camptothecin results in decreased expression of BAX mRNA; Camptothecin results in decreased expression of BAX protein
CTD
PMID:11279278 PMID:15665116 PMID:17555331 PMID:19481069 PMID:30581319 PMID:30885713 More...
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bbc3
Bcl-2 binding component 3
affects response to substance increases expression
ISO
BBC3 protein affects the susceptibility to Camptothecin Camptothecin results in increased expression of BBC3 mRNA
CTD
PMID:20477944 PMID:38460933
NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509
G
Bcl2
BCL2, apoptosis regulator
multiple interactions decreases response to substance decreases expression increases expression
ISO
3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole promotes the reaction [Camptothecin results in decreased expression of BCL2 protein]; Diethylhexyl Phthalate inhibits the reaction [Camptothecin results in decreased expression of BCL2 protein]; Folic Acid inhibits the reaction [Camptothecin results in decreased expression of BCL2 mRNA] BCL2 results in decreased susceptibility to Camptothecin Camptothecin results in decreased expression of BCL2 mRNA; Camptothecin results in decreased expression of BCL2 protein Camptothecin results in increased expression of BCL2 mRNA Camptothecin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BCL2 protein]
CTD
PMID:9664115 PMID:10692111 PMID:10896673 PMID:19481069 PMID:24726431 PMID:25449198 PMID:30581319 PMID:36394428 More...
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
decreases response to substance decreases expression increases expression multiple interactions
EXP ISO
BCL2L1 gene mutant form results in decreased susceptibility to Camptothecin Camptothecin results in decreased expression of BCL2L1 protein alternative form Camptothecin results in increased expression of BCL2L1 protein Dexamethasone inhibits the reaction [Camptothecin results in decreased expression of BCL2L1 protein alternative form]; Mifepristone affects the reaction [Dexamethasone inhibits the reaction [Camptothecin results in decreased expression of BCL2L1 protein alternative form]]; Naphthoquinones analog promotes the reaction [Camptothecin results in increased expression of BCL2L1 protein] BCL2L1 mRNA results in decreased susceptibility to Camptothecin Folic Acid inhibits the reaction [Camptothecin results in decreased expression of BCL2L1 mRNA]
CTD
PMID:10970895 PMID:19339209 PMID:19497415 PMID:25269479 PMID:30581319
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
G
Becn1
beclin 1
multiple interactions increases expression
ISO
[Diethylhexyl Phthalate co-treated with Camptothecin] results in decreased expression of BECN1 protein; Egtazic Acid inhibits the reaction [Camptothecin results in increased expression of BECN1 protein]; EIF2S1 protein affects the reaction [Camptothecin results in increased expression of BECN1 protein]; staurosporine aglycone inhibits the reaction [Camptothecin results in increased expression of BECN1 protein]
CTD
PMID:30266318 PMID:36394428
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
G
Bex1
brain expressed X-linked 1
increases expression
ISO
Camptothecin results in increased expression of BEX2 mRNA
CTD
PMID:38460933
NCBI chr X:99,219,014...99,220,518
Ensembl chr X:99,219,014...99,220,958
G
Bex4
brain expressed, X-linked 4
increases expression
ISO
Camptothecin results in increased expression of BEX4 mRNA
CTD
PMID:38460933
NCBI chr X:99,131,985...99,133,417
Ensembl chr X:99,131,942...99,133,531
G
Bid
BH3 interacting domain death agonist
multiple interactions
ISO
[Camptothecin co-treated with 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole] results in increased cleavage of and results in decreased expression of BID protein; [Camptothecin co-treated with FAS protein] results in increased cleavage of BID protein; Camptothecin results in increased cleavage of and results in decreased expression of BID protein
CTD
PMID:19481069 PMID:19633536
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
G
Bik
BCL2-interacting killer
increases expression
ISO
Camptothecin results in increased expression of BIK mRNA
CTD
PMID:38460933
NCBI chr 7:114,672,277...114,691,296
Ensembl chr 7:114,672,277...114,691,296
G
Birc5
baculoviral IAP repeat-containing 5
multiple interactions increases expression decreases expression
ISO
[Butyrates co-treated with Camptothecin] results in decreased expression of BIRC5 protein; [Folic Acid co-treated with Camptothecin] results in decreased expression of BIRC5 mRNA Camptothecin results in increased expression of BIRC5 mRNA Camptothecin results in decreased expression of BIRC5 mRNA Camptothecin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BIRC5 protein]
CTD
PMID:16061681 PMID:24726431 PMID:25449198 PMID:30581319
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
G
Blnk
B-cell linker
increases expression
ISO
Camptothecin results in increased expression of BLNK mRNA
CTD
PMID:38460933
NCBI chr 1:239,753,640...239,821,113
Ensembl chr 1:239,753,648...239,821,113
G
Bloc1s2
biogenesis of lysosomal organelles complex-1, subunit 2
increases expression
ISO
Camptothecin results in increased expression of BLOC1S2 mRNA
CTD
PMID:38460933
NCBI chr 1:243,024,611...243,031,749
Ensembl chr 1:243,024,614...243,031,653
G
Bnip1
BCL2 interacting protein 1
increases expression
ISO
Camptothecin results in increased expression of BNIP1 mRNA
CTD
PMID:33770205
NCBI chr10:16,386,876...16,399,124
Ensembl chr10:16,386,841...16,399,157
G
Brca1
BRCA1, DNA repair associated
decreases expression decreases response to substance
ISO
Camptothecin results in decreased expression of BRCA1 mRNA BRCA1 mRNA results in decreased susceptibility to Camptothecin
CTD
PMID:10344722 PMID:25269479
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
G
Brca2
BRCA2, DNA repair associated
decreases expression
ISO
Camptothecin results in decreased expression of BRCA2 mRNA
CTD
PMID:10344722
NCBI chr12:59,492...103,789
Ensembl chr12:59,819...100,567
G
Bscl2
BSCL2 lipid droplet biogenesis associated, seipin
increases expression
ISO
Camptothecin results in increased expression of BSCL2 mRNA
CTD
PMID:22003191
NCBI chr 1:205,731,828...205,743,430
Ensembl chr 1:205,733,872...205,743,421
G
Btbd19
BTB domain containing 19
increases expression
ISO
Camptothecin results in increased expression of BTBD19 mRNA
CTD
PMID:38460933
NCBI chr 5:130,596,966...130,605,403
Ensembl chr 5:130,597,684...130,604,335
G
Btg2
BTG anti-proliferation factor 2
increases expression
ISO
Camptothecin results in increased expression of BTG2 mRNA
CTD
PMID:38460933
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
G
C13h1orf116
similar to human chromosome 1 open reading frame 116
increases expression
ISO
Camptothecin results in increased expression of C1ORF116 mRNA
CTD
PMID:38460933
NCBI chr13:42,187,442...42,201,432
Ensembl chr13:42,188,609...42,201,426
G
C5ar1
complement C5a receptor 1
increases expression
ISO
Camptothecin results in increased expression of C5AR1 mRNA
CTD
PMID:38460933
NCBI chr 1:76,948,622...76,959,826
G
C7h22orf23
similar to human chromosome 22 open reading frame 23
increases expression
ISO
Camptothecin results in increased expression of C22ORF23 mRNA
CTD
PMID:38460933
NCBI chr 7:110,704,894...110,712,485
Ensembl chr 7:110,704,894...110,712,487
G
Cab39
calcium binding protein 39
decreases expression
ISO
Camptothecin results in decreased expression of CAB39 mRNA
CTD
PMID:17374387
NCBI chr 9:86,463,095...86,524,545
Ensembl chr 9:86,463,095...86,524,544
G
Calcoco1
calcium binding and coiled coil domain 1
increases expression
ISO
Camptothecin results in increased expression of CALCOCO1 mRNA
CTD
PMID:38460933
NCBI chr 7:133,834,705...133,849,515
Ensembl chr 7:133,834,707...133,849,422
G
Camk2b
calcium/calmodulin-dependent protein kinase II beta
increases expression
ISO
Camptothecin results in increased expression of CAMK2B mRNA
CTD
PMID:38460933
NCBI chr14:80,845,206...80,934,172
Ensembl chr14:80,845,238...80,933,994
G
Casp2
caspase 2
increases splicing increases expression
ISO
Camptothecin results in increased splicing of CASP2 mRNA Camptothecin results in increased expression of CASP2 mRNA alternative form
CTD
PMID:14757846
NCBI chr 4:71,149,632...71,167,388
Ensembl chr 4:71,149,669...71,167,379
G
Casp3
caspase 3
multiple interactions increases activity increases cleavage
ISO EXP
15-deoxyprostaglandin J2 promotes the reaction [Camptothecin results in increased activity of CASP3 protein]; 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole promotes the reaction [Camptothecin results in increased activity of CASP3 protein]; 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Camptothecin results in increased activity of CASP3 protein]; 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide promotes the reaction [Camptothecin results in increased activity of CASP3 protein]; [Camptothecin co-treated with FAS protein] results in increased activity of CASP3 protein; [Camptothecin co-treated with FAS protein] results in increased cleavage of CASP3 protein; benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [Camptothecin results in increased cleavage of CASP3 protein]; Camptothecin promotes the reaction [15-deoxyprostaglandin J2 results in increased activity of CASP3 protein]; Diethylhexyl Phthalate inhibits the reaction [Camptothecin results in increased cleavage of CASP3 protein]; palbociclib inhibits the reaction [Camptothecin results in increased activity of CASP3 protein]; SMN1 mRNA affects the reaction [Camptothecin results in increased activity of CASP3 protein]; THBS1 protein inhibits the reaction [Camptothecin results in increased activity of CASP3 protein] Cadmium Chloride inhibits the reaction [Camptothecin results in increased cleavage of CASP3 protein]; Cadmium inhibits the reaction [Camptothecin results in increased cleavage of CASP3 protein]; Dexamethasone inhibits the reaction [Camptothecin results in increased activity of CASP3 protein]; Naphthoquinones analog inhibits the reaction [Camptothecin results in increased activity of CASP3 protein]; Tetrachlorodibenzodioxin promotes the reaction [Camptothecin results in increased cleavage of CASP3 protein]
CTD
PMID:10896673 PMID:15862279 PMID:15958570 PMID:16263807 PMID:16273314 PMID:16756956 PMID:16962673 PMID:18506790 PMID:19339209 PMID:19481069 PMID:19497415 PMID:19633536 PMID:21683069 PMID:22302033 PMID:24726431 PMID:24792648 PMID:25412314 PMID:25592883 PMID:25843524 PMID:29384525 PMID:30720231 PMID:33248029 PMID:34635930 More...
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp4
caspase 4
increases expression
ISO
Camptothecin results in increased expression of CASP4 mRNA
CTD
PMID:38460933
NCBI chr 8:2,599,017...2,635,097
Ensembl chr 8:2,598,876...2,635,092
G
Casp7
caspase 7
multiple interactions increases activity decreases expression
ISO
6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Camptothecin results in increased activity of CASP7 protein]; 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide promotes the reaction [Camptothecin results in increased activity of CASP7 protein]; palbociclib inhibits the reaction [Camptothecin results in increased activity of CASP7 protein] Camptothecin results in decreased expression of CASP7 mRNA
CTD
PMID:22302033 PMID:24726431 PMID:30581319
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
G
Casp8
caspase 8
multiple interactions affects cleavage increases activity increases expression decreases expression
ISO EXP
3-(3-chloro-4-hydroxyphenylamino)-4-(4-nitrophenyl)-1H-pyrrole-2,5-dione inhibits the reaction [Camptothecin results in increased activity of CASP8 protein]; [Camptothecin co-treated with FAS protein] results in increased activity of CASP8 protein; [Camptothecin co-treated with FAS protein] results in increased cleavage of CASP8 protein; Lithium inhibits the reaction [Camptothecin results in increased activity of CASP8 protein]; MAD2L1 protein affects the reaction [Camptothecin results in increased expression of CASP8 protein] Camptothecin affects the cleavage of CASP8 protein Naphthoquinones analog inhibits the reaction [Camptothecin results in increased activity of CASP8 protein] Camptothecin results in decreased expression of CASP8 mRNA
CTD
PMID:10896673 PMID:15475000 PMID:15958570 PMID:19497415 PMID:19633536 PMID:30581319 PMID:30885713 PMID:34635930 More...
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
multiple interactions increases activity increases cleavage increases expression decreases expression
ISO EXP
[Camptothecin co-treated with FAS protein] results in increased activity of CASP9 protein; [Camptothecin co-treated with FAS protein] results in increased cleavage of CASP9 protein; MAD2L1 protein affects the reaction [Camptothecin results in increased expression of CASP9 protein] benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [Camptothecin results in increased cleavage of CASP9 protein]; Cadmium Chloride inhibits the reaction [Camptothecin results in increased activity of CASP9 protein]; Cadmium inhibits the reaction [Camptothecin results in increased activity of CASP9 protein]; Naphthoquinones analog inhibits the reaction [Camptothecin results in increased activity of CASP9 protein] Camptothecin results in decreased expression of CASP9 mRNA
CTD
PMID:10896673 PMID:15958570 PMID:16263807 PMID:19497415 PMID:19633536 PMID:24823293 PMID:30581319 PMID:30885713 PMID:34635930 More...
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cat
catalase
increases activity multiple interactions
EXP
Camptothecin results in increased activity of CAT protein alpha-Tocopherol inhibits the reaction [Camptothecin results in increased activity of CAT protein]
CTD
PMID:25304969
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cav1
caveolin 1
decreases methylation
ISO
Camptothecin results in decreased methylation of CAV1 gene
CTD
PMID:30720231
NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705
G
Ccdc63
coiled-coil domain containing 63
increases expression
ISO
Camptothecin results in increased expression of CCDC63 mRNA
CTD
PMID:38460933
NCBI chr12:34,424,388...34,453,080
Ensembl chr12:34,424,344...34,453,085
G
Ccdc69
coiled-coil domain containing 69
increases expression
ISO
Camptothecin results in increased expression of CCDC69 mRNA
CTD
PMID:38460933
NCBI chr10:39,173,282...39,200,358
Ensembl chr10:39,173,282...39,199,878
G
Ccdc88b
coiled-coil domain containing 88B
increases expression
ISO
Camptothecin results in increased expression of CCDC88B mRNA
CTD
PMID:38460933
NCBI chr 1:204,036,913...204,052,878
Ensembl chr 1:204,036,918...204,052,970
G
Ccl2
C-C motif chemokine ligand 2
decreases expression
ISO
Camptothecin results in decreased expression of CCL2 protein
CTD
PMID:20116850
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl26
C-C motif chemokine ligand 26
increases expression
ISO
Camptothecin results in increased expression of CCL26 mRNA
CTD
PMID:38460933
NCBI chr12:21,109,384...21,114,336
Ensembl chr12:21,109,421...21,114,335
G
Ccl4
C-C motif chemokine ligand 4
decreases expression
ISO
Camptothecin results in decreased expression of CCL4 protein
CTD
PMID:20116850
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
G
Ccl5
C-C motif chemokine ligand 5
decreases expression
ISO
Camptothecin results in decreased expression of CCL5 protein
CTD
PMID:20116850
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Ccna2
cyclin A2
multiple interactions decreases expression
ISO
[Folic Acid co-treated with Camptothecin] results in decreased expression of CCNA2 mRNA Camptothecin results in decreased expression of CCNA2 mRNA
CTD
PMID:30581319
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
G
Ccnb1
cyclin B1
multiple interactions increases expression decreases expression
ISO
[Butyrates co-treated with Camptothecin] results in decreased expression of CCNB1 protein; CDKN1A protein affects the reaction [Camptothecin results in increased expression of CCNB1 protein]; MAD2L1 protein affects the reaction [Camptothecin results in increased expression of CCNB1 protein]; MAPK8 protein affects the reaction [Camptothecin results in increased expression of CCNB1 protein] Camptothecin results in decreased expression of CCNB1 protein
CTD
PMID:16061681 PMID:23376119 PMID:30851366 PMID:30885713 PMID:31255635
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
G
Ccnd1
cyclin D1
affects localization
ISO
Camptothecin affects the localization of CCND1 protein
CTD
PMID:14647467
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Ccne1
cyclin E1
increases expression
ISO
Camptothecin results in increased expression of CCNE1 protein
CTD
PMID:30851366
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
G
Ccng2
cyclin G2
increases expression
ISO
Camptothecin results in increased expression of CCNG2 mRNA
CTD
PMID:38460933
NCBI chr14:14,804,321...14,812,819
Ensembl chr14:14,804,322...14,812,830
G
Cd164l2
CD164 molecule like 2
increases expression
ISO
Camptothecin results in increased expression of CD164L2 mRNA
CTD
PMID:38460933
NCBI chr 5:145,414,805...145,427,747
Ensembl chr 5:145,423,892...145,427,720
G
Cd82
Cd82 molecule
increases expression
ISO
Camptothecin results in increased expression of CD82 mRNA
CTD
PMID:38460933
NCBI chr 3:79,387,361...79,431,847
Ensembl chr 3:79,385,887...79,431,809
G
Cdc20
cell division cycle 20
multiple interactions
ISO
Camptothecin promotes the reaction [MAD2L1 protein binds to CDC20 protein]
CTD
PMID:30885713
NCBI chr 5:131,966,203...131,970,406
Ensembl chr 5:131,966,215...131,970,512
G
Cdc42bpg
CDC42 binding protein kinase gamma
increases expression
ISO
Camptothecin results in increased expression of CDC42BPG mRNA
CTD
PMID:38460933
NCBI chr 1:203,608,339...203,628,502
Ensembl chr 1:203,608,574...203,628,502
G
Cdh3
cadherin 3
increases expression
ISO
Camptothecin results in increased expression of CDH3 mRNA
CTD
PMID:38460933
NCBI chr19:34,393,596...34,444,084
Ensembl chr19:34,393,727...34,444,084
G
Cdip1
cell death-inducing p53 target 1
increases expression
ISO
Camptothecin results in increased expression of CDIP1 mRNA
CTD
PMID:38460933
NCBI chr10:10,773,538...10,796,979
Ensembl chr10:10,774,705...10,796,980
G
Cdk1
cyclin-dependent kinase 1
multiple interactions
ISO
Camptothecin results in increased expression of and results in increased activity of CDK1 protein; CDKN1A protein affects the reaction [Camptothecin results in increased activity of CDK1 protein]; MAD2L1 protein affects the reaction [Camptothecin results in increased expression of and results in increased activity of CDK1 protein]; MAPK8 protein affects the reaction [Camptothecin results in increased expression of CDK1 protein]
CTD
PMID:30885713
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
G
Cdk2
cyclin dependent kinase 2
multiple interactions increases activity
ISO EXP
Camptothecin results in increased phosphorylation of and results in decreased activity of CDK2 protein camptothecin increases kinase activity in rat cerebellar granule neurons
CTD RGD
PMID:15141020 PMID:19151707
RGD:10053571
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
G
Cdk5
cyclin-dependent kinase 5
increases activity
EXP
camptothecin increases kinase activity in rat cerebellar granule neurons
RGD
PMID:19151707
RGD:10053571
NCBI chr 4:10,754,682...10,760,110
Ensembl chr 4:10,754,687...10,760,112
G
Cdk5r1
cyclin-dependent kinase 5 regulatory subunit 1
increases expression
ISO
Camptothecin results in increased expression of CDK5R1 mRNA
CTD
PMID:33770205
NCBI chr10:65,484,266...65,485,467
Ensembl chr10:65,483,941...65,488,456
G
Cdk6
cyclin-dependent kinase 6
increases activity
EXP
camptothecin increases kinase activity in rat cerebellar granule neurons
RGD
PMID:19151707
RGD:10053571
NCBI chr 4:30,637,650...30,829,688
Ensembl chr 4:30,646,460...30,829,634
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
multiple interactions increases expression
ISO
Aspirin inhibits the reaction [Camptothecin results in increased expression of CDKN1A protein]; Camptothecin results in increased expression of and results in increased phosphorylation of CDKN1A protein; CDKN1A protein affects the reaction [Camptothecin results in increased activity of CDK1 protein]; CDKN1A protein affects the reaction [Camptothecin results in increased expression of CCNB1 protein]; CDKN1A protein affects the reaction [Camptothecin results in increased expression of MAD2L1 protein] Camptothecin results in increased expression of CDKN1A mRNA; Camptothecin results in increased expression of CDKN1A protein
CTD
PMID:9673414 PMID:17555331 PMID:19212664 PMID:24211769 PMID:30022047 PMID:30851366 PMID:30885713 More...
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Ceacam1
CEA cell adhesion molecule 1
increases expression
ISO
Camptothecin results in increased expression of CEACAM1 mRNA
CTD
PMID:17374387 PMID:38460933
NCBI chr 1:81,043,595...81,060,050
Ensembl chr 1:81,043,595...81,059,992
G
Cebpz
CCAAT/enhancer binding protein zeta
decreases expression
ISO
Camptothecin results in decreased expression of CEBPZ mRNA
CTD
PMID:17374387
NCBI chr 6:16,119,871...16,137,600
Ensembl chr 6:16,119,872...16,137,600
G
Cep85l
centrosomal protein 85-like
increases methylation
ISO
Camptothecin results in increased methylation of CEP85L gene
CTD
PMID:30720231
NCBI chr20:32,568,417...32,739,449
Ensembl chr20:32,572,741...32,739,516
G
Cfap96
cilia and flagella associated protein 96
increases expression
ISO
Camptothecin results in increased expression of C4ORF47 mRNA
CTD
PMID:38460933
NCBI chr16:46,291,075...46,315,616
Ensembl chr16:46,291,311...46,315,625
G
Cflar
CASP8 and FADD-like apoptosis regulator
multiple interactions
ISO
Camptothecin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CFLAR protein]
CTD
PMID:25449198
NCBI chr 9:60,185,338...60,236,173
Ensembl chr 9:60,185,452...60,237,034
G
Chek1
checkpoint kinase 1
multiple interactions increases phosphorylation increases expression decreases response to substance
ISO
2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [Camptothecin results in increased phosphorylation of CHEK1 protein]; 7-hydroxystaurosporine inhibits the reaction [Camptothecin results in increased expression of CHEK1 mRNA]; 7-hydroxystaurosporine inhibits the reaction [Camptothecin results in increased phosphorylation of CHEK1 protein]; Caffeine inhibits the reaction [Camptothecin results in increased expression of CHEK1 mRNA]; Caffeine inhibits the reaction [Camptothecin results in increased phosphorylation of CHEK1 protein] 3-amino-6-(4-(methylsulfonyl)phenyl)-N-phenylpyrazine-2-carboxamide inhibits the reaction [Camptothecin results in increased expression of CHEK1 protein modified form]; Diethylhexyl Phthalate inhibits the reaction [Camptothecin results in increased expression of CHEK1 protein modified form] CHEK1 mRNA results in decreased susceptibility to Camptothecin
CTD
PMID:21646468 PMID:22403396 PMID:25269479 PMID:30555576 PMID:30720231
NCBI chr 8:36,420,565...36,443,477
Ensembl chr 8:36,420,569...36,441,009
G
Chek2
checkpoint kinase 2
increases expression increases phosphorylation multiple interactions
ISO
Camptothecin results in increased expression of CHEK2 protein modified form Camptothecin results in increased phosphorylation of CHEK2 protein Diethylhexyl Phthalate inhibits the reaction [Camptothecin results in increased expression of CHEK2 protein modified form]
CTD
PMID:21646468 PMID:25269479 PMID:25977998 PMID:30720231
NCBI chr12:45,788,823...45,821,382
Ensembl chr12:45,788,827...45,821,286
G
Chga
chromogranin A
increases expression
ISO
Camptothecin results in increased expression of CHGA mRNA
CTD
PMID:38460933
NCBI chr 6:121,696,051...121,707,399
Ensembl chr 6:121,696,051...121,707,398
G
Chgb
chromogranin B
increases expression
ISO
Camptothecin results in increased expression of CHGB mRNA
CTD
PMID:38460933
NCBI chr 3:120,043,824...120,057,169
Ensembl chr 3:120,043,738...120,057,166
G
Chrna9
cholinergic receptor nicotinic alpha 9 subunit
increases expression
ISO
Camptothecin results in increased expression of CHRNA9 mRNA
CTD
PMID:38460933
NCBI chr14:42,235,218...42,241,939
Ensembl chr14:42,235,226...42,242,192
G
Chst2
carbohydrate sulfotransferase 2
increases expression
ISO
Camptothecin results in increased expression of CHST2 mRNA
CTD
PMID:38460933
NCBI chr 8:95,960,067...95,966,312
Ensembl chr 8:95,959,826...95,966,955
G
Cimap1c
ciliary microtubule associated protein 1C
increases expression
ISO
Camptothecin results in increased expression of ODF3L1 mRNA
CTD
PMID:38460933
NCBI chr 8:57,248,746...57,281,084
Ensembl chr 8:57,248,746...57,281,004
G
Clptm1l
CLPTM1-like
increases response to substance
ISO
CLPTM1L mutant form results in increased susceptibility to Camptothecin
CTD
PMID:22675468
NCBI chr 1:29,667,545...29,683,530
Ensembl chr 1:29,667,545...29,683,530
G
Cltrn
collectrin, amino acid transport regulator
increases expression
ISO
Camptothecin results in increased expression of TMEM27 mRNA
CTD
PMID:38460933
NCBI chr X:30,361,967...30,395,264
Ensembl chr X:30,361,967...30,395,349
G
Cnfn
cornifelin
increases expression
ISO
Camptothecin results in increased expression of CNFN mRNA
CTD
PMID:38460933
NCBI chr 1:80,949,699...80,953,747
Ensembl chr 1:80,951,600...80,953,747
G
Coil
coilin
increases expression
ISO
Camptothecin results in increased expression of COIL mRNA
CTD
PMID:33770205
NCBI chr10:73,789,077...73,810,378
Ensembl chr10:73,789,488...73,810,393
G
Col17a1
collagen type XVII alpha 1 chain
increases expression
ISO
Camptothecin results in increased expression of COL17A1 mRNA
CTD
PMID:38460933
NCBI chr 1:246,530,589...246,577,559
Ensembl chr 1:246,531,367...246,577,632
G
Col9a2
collagen type IX alpha 2 chain
increases expression
ISO
Camptothecin results in increased expression of COL9A2 mRNA
CTD
PMID:38460933
NCBI chr 5:134,607,616...134,624,678
Ensembl chr 5:134,607,616...134,624,677
G
Coro2a
coronin 2A
increases expression
ISO
Camptothecin results in increased expression of CORO2A mRNA
CTD
PMID:38460933
NCBI chr 5:60,825,630...60,881,917
Ensembl chr 5:60,828,247...60,859,035
G
Cpa4
carboxypeptidase A4
increases expression
ISO
Camptothecin results in increased expression of CPA4 mRNA
CTD
PMID:38460933
NCBI chr 4:59,188,284...59,212,255
Ensembl chr 4:59,188,284...59,212,255
G
Cpe
carboxypeptidase E
increases expression
ISO
Camptothecin results in increased expression of CPE mRNA
CTD
PMID:38460933
NCBI chr16:25,030,276...25,142,231
Ensembl chr16:25,030,276...25,142,233
G
Crabp2
cellular retinoic acid binding protein 2
increases expression
ISO
Camptothecin results in increased expression of CRABP2 mRNA
CTD
PMID:38460933
NCBI chr 2:173,417,004...173,421,352
Ensembl chr 2:173,416,857...173,421,379
G
Crebbp
CREB binding protein
multiple interactions
EXP
Camptothecin inhibits the reaction [RELA protein binds to CREBBP protein]; Camptothecin promotes the reaction [TP53 protein binds to CREBBP protein]; pifithrin inhibits the reaction [Camptothecin inhibits the reaction [RELA protein binds to CREBBP protein]]; pifithrin inhibits the reaction [Camptothecin promotes the reaction [TP53 protein binds to CREBBP protein]]
CTD
PMID:13679428
NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888
G
Crx
cone-rod homeobox
decreases response to substance
ISO
CRX mRNA results in decreased susceptibility to Camptothecin
CTD
PMID:25269479
NCBI chr 1:76,539,812...76,553,694
Ensembl chr 1:76,540,141...76,545,818
G
Cryab
crystallin, alpha B
increases expression
ISO
Camptothecin results in increased expression of CRYAB mRNA
CTD
PMID:38460933
NCBI chr 8:51,093,441...51,099,161
Ensembl chr 8:51,093,441...51,099,157
G
Csdc2
cold shock domain containing C2
increases expression
ISO
Camptothecin results in increased expression of CSDC2 mRNA
CTD
PMID:38460933
NCBI chr 7:113,451,998...113,466,464
Ensembl chr 7:113,451,998...113,466,463
G
Csta
cystatin A
increases expression
ISO
Camptothecin results in increased expression of CSTA mRNA
CTD
PMID:38460933
NCBI chr11:64,620,483...64,631,488
Ensembl chr11:64,620,483...64,631,488
G
Cthrc1
collagen triple helix repeat containing 1
increases expression
ISO
Camptothecin results in increased expression of CTHRC1 mRNA
CTD
PMID:38460933
NCBI chr 7:70,122,474...70,132,756
Ensembl chr 7:70,122,474...70,132,756
G
Ctsb
cathepsin B
multiple interactions
ISO
CTSB protein results in increased cleavage of [Camptothecin analog binds to ALB protein]
CTD
PMID:17378599
NCBI chr15:37,389,636...37,410,508
Ensembl chr15:37,389,629...37,410,500
G
Ctsh
cathepsin H
increases expression
ISO
Camptothecin results in increased expression of CTSH mRNA
CTD
PMID:38460933
NCBI chr 8:90,608,941...90,627,824
Ensembl chr 8:90,608,941...90,627,824
G
Cxxc4
CXXC finger protein 4
increases expression
ISO
Camptothecin results in increased expression of CXXC4 mRNA
CTD
PMID:38460933
NCBI chr 2:222,664,148...222,689,365
Ensembl chr 2:222,664,771...222,689,365
G
Cycs
cytochrome c, somatic
multiple interactions affects localization
ISO
3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole promotes the reaction [Camptothecin affects the localization of CYCS protein]
CTD
PMID:19481069
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
G
Cyp26b1
cytochrome P450, family 26, subfamily b, polypeptide 1
decreases response to substance
ISO
CYP26B1 mRNA results in decreased susceptibility to Camptothecin
CTD
PMID:25269479
NCBI chr 4:117,041,808...117,058,628
Ensembl chr 4:117,041,808...117,058,628
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
decreases expression multiple interactions
ISO
Camptothecin results in decreased expression of CYP2B6 mRNA Camptothecin inhibits the reaction [Rifampin results in increased expression of CYP2B6 mRNA]
CTD
PMID:29356861
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
G
Cyp2c79
cytochrome P450, family 2, subfamily c, polypeptide 79
decreases expression multiple interactions
ISO
Camptothecin results in decreased expression of CYP2C8 mRNA Camptothecin inhibits the reaction [Rifampin results in increased expression of CYP2C8 mRNA]
CTD
PMID:29356861
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
multiple interactions
ISO
Camptothecin inhibits the reaction [Rifampin results in increased expression of CYP3A4 mRNA]
CTD
PMID:29356861
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Ddit3
DNA-damage inducible transcript 3
multiple interactions increases expression decreases expression
ISO
Folic Acid inhibits the reaction [Camptothecin results in decreased expression of DDIT3 mRNA]; MYC protein affects the reaction [Camptothecin results in increased expression of DDIT3 protein] Camptothecin results in increased expression of DDIT3 mRNA; Camptothecin results in increased expression of DDIT3 protein
CTD
PMID:30266318 PMID:30581319 PMID:38460933
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Ddit4l
DNA-damage-inducible transcript 4-like
increases expression
ISO
Camptothecin results in increased expression of DDIT4L mRNA
CTD
PMID:38460933
NCBI chr 2:226,128,273...226,131,044
Ensembl chr 2:226,128,276...226,131,375
G
Def6
DEF6 guanine nucleotide exchange factor
increases expression
ISO
Camptothecin results in increased expression of DEF6 mRNA
CTD
PMID:38460933
NCBI chr20:6,268,579...6,290,030
Ensembl chr20:6,268,601...6,289,961
G
Dgkz
diacylglycerol kinase zeta
decreases response to substance
ISO
DGKZ mRNA results in decreased susceptibility to Camptothecin
CTD
PMID:25269479
NCBI chr 3:77,904,149...77,946,114
Ensembl chr 3:77,904,150...77,946,099
G
Dnah10
dynein, axonemal, heavy chain 10
increases expression
ISO
Camptothecin results in increased expression of DNAH10 mRNA
CTD
PMID:38460933
NCBI chr12:31,823,451...31,946,857
Ensembl chr12:31,822,733...32,007,069
G
Dnai3
dynein axonemal intermediate chain 3
increases expression
ISO
Camptothecin results in increased expression of WDR63 mRNA
CTD
PMID:38460933
NCBI chr 2:234,947,910...235,006,173
Ensembl chr 2:234,929,677...235,006,173
G
Dock8
dedicator of cytokinesis 8
increases expression
ISO
Camptothecin results in increased expression of DOCK8 mRNA
CTD
PMID:38460933
NCBI chr 1:222,649,309...222,842,474
Ensembl chr 1:222,649,309...222,842,474
G
Dpyd
dihydropyrimidine dehydrogenase
multiple interactions decreases expression decreases activity
ISO
Camptothecin inhibits the reaction [Fluorouracil results in increased expression of DPYD mRNA] Camptothecin results in decreased expression of DPYD mRNA Camptothecin results in decreased activity of DPYD protein
CTD
PMID:16568373
NCBI chr 2:206,609,043...207,474,982
Ensembl chr 2:206,609,122...207,474,982
G
Dpysl4
dihydropyrimidinase-like 4
increases expression
ISO
Camptothecin results in increased expression of DPYSL4 mRNA
CTD
PMID:38460933
NCBI chr 1:193,883,039...193,898,916
Ensembl chr 1:193,883,106...193,898,914
G
Dqx1
DEAQ box RNA-dependent ATPase 1
increases expression
ISO
Camptothecin results in increased expression of DQX1 mRNA
CTD
PMID:38460933
NCBI chr 4:115,563,497...115,572,598
Ensembl chr 4:115,563,752...115,572,590
G
Draxin
dorsal inhibitory axon guidance protein
increases expression
ISO
Camptothecin results in increased expression of DRAXIN mRNA
CTD
PMID:38460933
NCBI chr 5:158,530,149...158,563,457
Ensembl chr 5:158,530,342...158,564,483
G
Dsc3
desmocollin 3
increases expression
ISO
Camptothecin results in increased expression of DSC3 mRNA
CTD
PMID:38460933
NCBI chr18:11,379,759...11,413,797
Ensembl chr18:11,377,347...11,413,797
G
Dsel
dermatan sulfate epimerase-like
increases expression
ISO
Camptothecin results in increased expression of DSEL mRNA
CTD
PMID:38460933
NCBI chr13:186,413...192,592
Ensembl chr13:175,805...192,647
G
Dtwd1
DTW domain containing 1
increases expression
ISO
Camptothecin results in increased expression of DTWD1 mRNA
CTD
PMID:33770205
NCBI chr 3:113,392,402...113,409,322
Ensembl chr 3:113,392,457...113,408,105
G
Dusp14
dual specificity phosphatase 14
increases expression
ISO
Camptothecin results in increased expression of DUSP14 mRNA
CTD
PMID:38460933
NCBI chr10:68,936,483...68,966,347
Ensembl chr10:68,935,330...68,965,329
G
Dusp15
dual specificity phosphatase 15
increases expression
ISO
Camptothecin results in increased expression of DUSP15 mRNA
CTD
PMID:38460933
NCBI chr 3:141,408,495...141,419,137
Ensembl chr 3:141,408,498...141,418,999
G
Dyrk3
dual specificity tyrosine phosphorylation regulated kinase 3
increases expression
ISO
Camptothecin results in increased expression of DYRK3 mRNA
CTD
PMID:38460933
NCBI chr13:42,594,120...42,604,898
Ensembl chr13:42,594,121...42,604,778
G
E2f1
E2F transcription factor 1
multiple interactions increases expression
ISO
7-hydroxystaurosporine inhibits the reaction [Camptothecin results in increased expression of E2F1 mRNA]; Caffeine inhibits the reaction [Camptothecin results in increased expression of E2F1 mRNA]; E2F1 protein promotes the reaction [Camptothecin results in increased expression of RRM2 protein]
CTD
PMID:22403396
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
G
E2f8
E2F transcription factor 8
increases expression
ISO
Camptothecin results in increased expression of E2F8 mRNA
CTD
PMID:33770205
NCBI chr 1:98,565,717...98,584,265
Ensembl chr 1:98,565,717...98,584,098
G
Ebi3
Epstein-Barr virus induced 3
increases expression
ISO
Camptothecin results in increased expression of EBI3 mRNA
CTD
PMID:38460933
NCBI chr 9:774,252...787,544
Ensembl chr 9:783,617...787,544
G
Ecm1
extracellular matrix protein 1
increases expression
ISO
Camptothecin results in increased expression of ECM1 mRNA
CTD
PMID:38460933
NCBI chr 2:183,287,491...183,292,729
Ensembl chr 2:183,287,322...183,292,671
G
Efnb1
ephrin B1
increases expression
ISO
Camptothecin results in increased expression of EFNB1 mRNA
CTD
PMID:38460933
NCBI chr X:64,257,351...64,270,158
Ensembl chr X:64,257,351...64,270,157
G
Ei24
EI24, autophagy associated transmembrane protein
increases expression
ISO
Camptothecin results in increased expression of EI24 mRNA
CTD
PMID:17374387
NCBI chr 8:36,494,289...36,510,653
Ensembl chr 8:36,494,289...36,510,571
G
Eif2ak3
eukaryotic translation initiation factor 2 alpha kinase 3
multiple interactions increases phosphorylation
ISO
Glutathione inhibits the reaction [Camptothecin results in increased phosphorylation of EIF2AK3 protein]; MYC protein affects the reaction [Camptothecin results in increased phosphorylation of EIF2AK3 protein]
CTD
PMID:30266318
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
G
Eif2s1
eukaryotic translation initiation factor 2 subunit alpha
increases phosphorylation multiple interactions
ISO EXP
Camptothecin results in increased phosphorylation of EIF2S1 protein EIF2S1 protein affects the reaction [Camptothecin results in increased expression of ATG7 protein]; EIF2S1 protein affects the reaction [Camptothecin results in increased expression of BECN1 protein]; Glutathione inhibits the reaction [Camptothecin results in increased phosphorylation of EIF2S1 protein]; MYC protein affects the reaction [Camptothecin results in increased phosphorylation of EIF2S1 protein] [Camptothecin co-treated with GW 506033X] results in increased phosphorylation of EIF2S1 protein
CTD
PMID:19046382 PMID:30266318
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
G
Elovl3
ELOVL fatty acid elongase 3
increases expression
ISO
Camptothecin results in increased expression of ELOVL3 mRNA
CTD
PMID:38460933
NCBI chr 1:244,997,287...245,001,115
Ensembl chr 1:244,997,287...245,001,115
G
Enho
energy homeostasis associated
increases expression
ISO
Camptothecin results in increased expression of ENHO mRNA
CTD
PMID:38460933
NCBI chr 5:56,800,980...56,802,777
Ensembl chr 5:56,800,980...56,802,777
G
Eomes
eomesodermin
increases expression
ISO
Camptothecin results in increased expression of EOMES mRNA
CTD
PMID:38460933
NCBI chr 8:118,181,340...118,189,186
Ensembl chr 8:118,181,777...118,188,316
G
Ep300
E1A binding protein p300
decreases expression
ISO
Camptothecin results in decreased expression of EP300 mRNA; Camptothecin results in decreased expression of EP300 protein
CTD
PMID:10344722
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
G
Epm2aip1
EPM2A interacting protein 1
increases expression
ISO
Camptothecin results in increased expression of EPM2AIP1 mRNA
CTD
PMID:17374387
NCBI chr 8:111,233,871...111,241,219
Ensembl chr 8:111,233,826...111,241,871
G
Ercc1
ERCC excision repair 1, endonuclease non-catalytic subunit
multiple interactions decreases expression
ISO
ERCC1 protein promotes the reaction [veliparib promotes the reaction [Camptothecin results in increased expression of H2AX protein]] Camptothecin results in decreased expression of ERCC1 mRNA
CTD
PMID:21227924 PMID:24792648
NCBI chr 1:78,971,310...79,007,963
Ensembl chr 1:78,996,390...79,007,963
G
Ercc4
ERCC excision repair 4, endonuclease catalytic subunit
multiple interactions decreases response to substance
ISO
ERCC4 protein promotes the reaction [veliparib promotes the reaction [Camptothecin results in increased expression of H2AX protein]] ERCC4 protein results in decreased susceptibility to Camptothecin
CTD
PMID:21227924
NCBI chr10:2,416,259...2,448,364
Ensembl chr10:2,419,038...2,448,369
G
Esr1
estrogen receptor 1
multiple interactions
ISO
Camptothecin binds to and results in decreased activity of ESR1 protein; ESR1 promotes the reaction [Diethylhexyl Phthalate inhibits the reaction [Camptothecin results in increased expression of ATM protein modified form]]; ESR1 promotes the reaction [Diethylhexyl Phthalate inhibits the reaction [Camptothecin results in increased expression of H2AX protein modified form]]
CTD
PMID:25752796 PMID:30720231
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Esr2
estrogen receptor 2
multiple interactions
ISO
Camptothecin binds to and results in decreased activity of ESR2 protein
CTD
PMID:25752796
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
Exoc3l2
exocyst complex component 3-like 2
increases expression
ISO
Camptothecin results in increased expression of EXOC3L2 mRNA
CTD
PMID:38460933
NCBI chr 1:79,113,784...79,145,359
Ensembl chr 1:79,112,506...79,145,465
G
Fam210b
family with sequence similarity 210, member B
increases expression
ISO
Camptothecin results in increased expression of FAM210B mRNA
CTD
PMID:38460933
NCBI chr 3:161,118,228...161,128,400
Ensembl chr 3:161,118,239...161,128,397
G
Fam43a
family with sequence similarity 43, member A
increases expression
ISO
Camptothecin results in increased expression of FAM43A mRNA
CTD
PMID:38460933
NCBI chr11:70,128,253...70,131,401
Ensembl chr11:70,128,253...70,131,401
G
Fam43b
family with sequence similarity 43, member B
increases expression
ISO
Camptothecin results in increased expression of FAM43B mRNA
CTD
PMID:38460933
NCBI chr 5:150,610,656...150,613,054
Ensembl chr 5:150,611,609...150,612,601
G
Fam83h
family with sequence similarity 83, member H
increases expression
ISO
Camptothecin results in increased expression of FAM83H mRNA
CTD
PMID:38460933
NCBI chr 7:107,716,431...107,724,619
Ensembl chr 7:107,716,431...107,728,672
G
Fam98c
family with sequence similarity 98, member C
increases expression
ISO
Camptothecin results in increased expression of FAM98C mRNA
CTD
PMID:38460933
NCBI chr 1:84,452,806...84,456,414
Ensembl chr 1:84,452,814...84,456,385
G
Fas
Fas cell surface death receptor
multiple interactions increases expression
ISO
3-(3-chloro-4-hydroxyphenylamino)-4-(4-nitrophenyl)-1H-pyrrole-2,5-dione inhibits the reaction [Camptothecin results in increased expression of and affects the localization of FAS protein]; [Camptothecin co-treated with FAS protein] results in decreased expression of XIAP protein; [Camptothecin co-treated with FAS protein] results in increased activity of CASP3 protein; [Camptothecin co-treated with FAS protein] results in increased activity of CASP8 protein; [Camptothecin co-treated with FAS protein] results in increased activity of CASP9 protein; [Camptothecin co-treated with FAS protein] results in increased cleavage of BID protein; [Camptothecin co-treated with FAS protein] results in increased cleavage of CASP3 protein; [Camptothecin co-treated with FAS protein] results in increased cleavage of CASP8 protein; [Camptothecin co-treated with FAS protein] results in increased cleavage of CASP9 protein; Camptothecin results in increased expression of and affects the localization of FAS protein; Lithium inhibits the reaction [Camptothecin results in increased expression of and affects the localization of FAS protein] Camptothecin results in increased expression of FAS mRNA
CTD
PMID:15475000 PMID:15958570 PMID:19633536 PMID:38460933
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Fbxo2
F-box protein 2
increases expression
ISO
Camptothecin results in increased expression of FBXO2 mRNA
CTD
PMID:38460933
NCBI chr 5:158,592,926...158,598,355
Ensembl chr 5:158,592,925...158,598,355
G
Fdxr
ferredoxin reductase
increases expression
ISO
Camptothecin results in increased expression of FDXR mRNA
CTD
PMID:17374387
NCBI chr10:100,507,863...100,516,649
Ensembl chr10:100,507,865...100,516,658
G
Fez1
fasciculation and elongation protein zeta 1
increases expression
ISO
Camptothecin results in increased expression of FEZ1 mRNA
CTD
PMID:38460933
NCBI chr 8:36,544,462...36,589,684
Ensembl chr 8:36,544,535...36,589,683
G
Fgd3
FYVE, RhoGEF and PH domain containing 3
increases expression
ISO
Camptothecin results in increased expression of FGD3 mRNA
CTD
PMID:38460933
NCBI chr17:15,324,848...15,387,271
Ensembl chr17:15,336,837...15,385,712
G
Fgfbp3
fibroblast growth factor binding protein 3
increases expression
ISO
Camptothecin results in increased expression of FGFBP3 mRNA
CTD
PMID:38460933
NCBI chr 1:234,644,023...234,646,028
Ensembl chr 1:234,644,019...234,646,547
G
Foxd3
forkhead box D3
increases expression
ISO
Camptothecin results in increased expression of FOXD3 mRNA
CTD
PMID:38460933
NCBI chr 5:114,335,084...114,337,450
Ensembl chr 5:114,335,408...114,336,817
G
Frzb
frizzled-related protein
increases expression
ISO
Camptothecin results in increased expression of FRZB mRNA
CTD
PMID:38460933
NCBI chr 3:65,332,274...65,365,208
Ensembl chr 3:65,332,277...65,365,208
G
Fxn
frataxin
increases expression
ISO
Camptothecin results in increased expression of FXN protein
CTD
PMID:23418481
NCBI chr 1:221,874,007...221,897,543
Ensembl chr 1:221,872,420...221,897,540
G
Fxyd3
FXYD domain-containing ion transport regulator 3
increases expression
ISO
Camptothecin results in increased expression of FXYD3 mRNA
CTD
PMID:38460933
NCBI chr 1:86,305,531...86,312,455
G
Fzd1
frizzled class receptor 1
decreases methylation
ISO
Camptothecin results in decreased methylation of FZD1 gene
CTD
PMID:30720231
NCBI chr 4:29,310,303...29,314,701
Ensembl chr 4:29,310,091...29,312,643 Ensembl chr 4:29,310,091...29,312,643
G
Fzd8
frizzled class receptor 8
decreases methylation
ISO
Camptothecin results in decreased methylation of FZD8 gene
CTD
PMID:30720231
NCBI chr17:57,312,924...57,320,551
Ensembl chr17:57,314,450...57,320,650
G
Gabbr2
gamma-aminobutyric acid type B receptor subunit 2
increases expression
ISO
Camptothecin results in increased expression of GABBR2 mRNA
CTD
PMID:38460933
NCBI chr 5:60,947,517...61,288,104
Ensembl chr 5:60,947,526...61,288,104
G
Gabrd
gamma-aminobutyric acid type A receptor subunit delta
increases expression
ISO
Camptothecin results in increased expression of GABRD mRNA
CTD
PMID:38460933
NCBI chr 5:165,958,508...165,970,407
Ensembl chr 5:165,958,484...165,970,411
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
decreases expression multiple interactions increases expression
ISO
Camptothecin results in decreased expression of GADD45A mRNA Folic Acid inhibits the reaction [Camptothecin results in decreased expression of GADD45A mRNA] Camptothecin results in increased expression of GADD45A mRNA
CTD
PMID:24792648 PMID:30581319 PMID:38460933
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
G
Gadd45g
growth arrest and DNA-damage-inducible, gamma
increases expression
ISO
Camptothecin results in increased expression of GADD45G mRNA
CTD
PMID:24792648
NCBI chr17:13,376,842...13,378,587
Ensembl chr17:13,376,839...13,378,610
G
Galnt5
polypeptide N-acetylgalactosaminyltransferase 5
increases expression
ISO
Camptothecin results in increased expression of GALNT5 mRNA
CTD
PMID:38460933
NCBI chr 3:42,573,622...42,619,881
Ensembl chr 3:42,573,622...42,619,881
G
Gast
gastrin
increases expression
ISO
Camptothecin results in increased expression of GAST mRNA
CTD
PMID:38460933
NCBI chr10:85,264,832...85,269,393
Ensembl chr10:85,264,832...85,267,496
G
Gch1
GTP cyclohydrolase 1
increases expression
ISO
Camptothecin results in increased expression of GCH1 mRNA
CTD
PMID:38460933
NCBI chr15:20,404,267...20,437,727
Ensembl chr15:20,402,527...20,437,698
G
Gdf15
growth differentiation factor 15
increases expression
ISO
Camptothecin results in increased expression of GDF15 mRNA
CTD
PMID:38460933
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
G
Gdpd1
glycerophosphodiester phosphodiesterase domain containing 1
increases expression
ISO
Camptothecin results in increased expression of GDPD1 mRNA
CTD
PMID:38460933
NCBI chr10:71,840,497...71,883,936
Ensembl chr10:71,840,497...71,883,850
G
Gipr
gastric inhibitory polypeptide receptor
increases expression
ISO
Camptothecin results in increased expression of GIPR mRNA
CTD
PMID:38460933
NCBI chr 1:78,804,287...78,814,462
Ensembl chr 1:78,805,593...78,814,462
G
Git2
GIT ArfGAP 2
decreases response to substance
ISO
GIT2 mRNA results in decreased susceptibility to Camptothecin
CTD
PMID:25269479
NCBI chr12:41,829,717...41,872,621
Ensembl chr12:41,829,730...41,871,097
G
Gjb3
gap junction protein, beta 3
increases expression
ISO
Camptothecin results in increased expression of GJB3 mRNA
CTD
PMID:38460933
NCBI chr 5:139,649,227...139,654,970
Ensembl chr 5:139,649,195...139,654,980
G
Gjd3
gap junction protein, delta 3
increases expression
ISO
Camptothecin results in increased expression of GJD3 mRNA
CTD
PMID:38460933
NCBI chr10:83,933,694...83,935,759
Ensembl chr10:83,934,135...83,934,971
G
Gkn2
gastrokine 2
increases expression
ISO
Camptothecin results in increased expression of GKN2 mRNA
CTD
PMID:38460933
NCBI chr 4:119,778,326...119,824,366
Ensembl chr 4:119,818,280...119,824,363
G
Glipr2
GLI pathogenesis-related 2
increases expression
ISO
Camptothecin results in increased expression of GLIPR2 mRNA
CTD
PMID:38460933
NCBI chr 5:58,170,417...58,202,258
Ensembl chr 5:58,170,425...58,202,272
G
Gls2
glutaminase 2
increases expression
ISO
Camptothecin results in increased expression of GLS2 mRNA
CTD
PMID:38460933
NCBI chr 7:617,252...633,424
Ensembl chr 7:617,288...633,426
G
Gm2a
ganglioside GM2 activator
increases expression
ISO
Camptothecin results in increased expression of GM2A mRNA
CTD
PMID:38460933
NCBI chr10:39,219,221...39,231,756
Ensembl chr10:39,219,243...39,231,757
G
Gmfg
glia maturation factor, gamma
increases expression
ISO
Camptothecin results in increased expression of GMFG mRNA
CTD
PMID:38460933
NCBI chr 1:83,728,797...83,739,189
Ensembl chr 1:83,728,776...83,739,183
G
Golt1a
golgi transport 1A
increases expression
ISO
Camptothecin results in increased expression of GOLT1A mRNA
CTD
PMID:38460933
NCBI chr13:44,760,356...44,773,123
Ensembl chr13:44,760,380...44,773,122
G
Gpr132
G protein-coupled receptor 132
increases expression
ISO
Camptothecin results in increased expression of GPR132 mRNA
CTD
PMID:38460933
NCBI chr 6:131,924,061...131,943,327
Ensembl chr 6:131,924,160...131,942,168
G
Gpr3
G protein-coupled receptor 3
increases expression
ISO
Camptothecin results in increased expression of GPR3 mRNA
CTD
PMID:38460933
NCBI chr 5:145,411,500...145,414,621
Ensembl chr 5:145,411,510...145,414,590
G
Gpr87
G protein-coupled receptor 87
increases expression
ISO
Camptothecin results in increased expression of GPR87 mRNA
CTD
PMID:38460933
NCBI chr 2:143,439,741...143,440,901
Ensembl chr 2:143,439,735...143,458,190
G
Gpx1
glutathione peroxidase 1
increases expression
ISO
Camptothecin results in increased expression of GPX1 mRNA
CTD
PMID:38460933
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
G
Gpx4
glutathione peroxidase 4
decreases response to substance
ISO
GPX4 mRNA results in decreased susceptibility to Camptothecin
CTD
PMID:25269479
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
G
Gramd2b
GRAM domain containing 2B
increases expression
ISO
Camptothecin results in increased expression of GRAMD3 mRNA
CTD
PMID:38460933
NCBI chr18:49,884,014...49,981,955
Ensembl chr18:49,884,014...49,981,953
G
Grhl3
grainyhead-like transcription factor 3
increases expression
ISO
Camptothecin results in increased expression of GRHL3 mRNA
CTD
PMID:38460933
NCBI chr 5:147,774,161...147,806,291
Ensembl chr 5:147,774,160...147,806,160
G
Grin3b
glutamate ionotropic receptor NMDA type subunit 3B
increases expression
ISO
Camptothecin results in increased expression of GRIN3B mRNA
CTD
PMID:38460933
NCBI chr 7:9,730,861...9,737,183
Ensembl chr 7:9,730,862...9,737,183
G
Gsr
glutathione-disulfide reductase
multiple interactions decreases activity
EXP
alpha-Tocopherol inhibits the reaction [Camptothecin results in decreased activity of GSR protein]
CTD
PMID:25304969
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
Gstp1
glutathione S-transferase pi 1
increases expression decreases response to substance
ISO
Camptothecin results in increased expression of GSTP1 protein GSTP1 protein polymorphism results in decreased susceptibility to Camptothecin; GSTP1 protein results in decreased susceptibility to Camptothecin
CTD
PMID:14732228 PMID:15500952
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
Gtf3c6
general transcription factor 3C subunit 6
increases expression
ISO
Camptothecin results in increased expression of GTF3C6 mRNA
CTD
PMID:38460933
NCBI chr20:43,656,400...43,668,382
Ensembl chr20:43,655,875...43,667,873
G
H2ax
H2A.X variant histone
multiple interactions increases expression increases phosphorylation
ISO EXP
3-amino-6-(4-(methylsulfonyl)phenyl)-N-phenylpyrazine-2-carboxamide inhibits the reaction [Camptothecin results in increased expression of H2AX protein modified form]; [Aminacrine results in decreased phosphorylation of H2AX protein] inhibits the reaction [Camptothecin results in increased activity of and affects the localization of MDC1 protein]; [MIR138-1 results in decreased expression of H2AX] which results in increased susceptibility to Camptothecin; [Propyl Gallate results in decreased phosphorylation of H2AX protein] inhibits the reaction [Camptothecin results in increased activity of and affects the localization of MDC1 protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [veliparib promotes the reaction [Camptothecin results in increased expression of H2AX protein]]; Diethylhexyl Phthalate inhibits the reaction [Camptothecin results in increased expression of H2AX protein modified form]; ERCC1 protein promotes the reaction [veliparib promotes the reaction [Camptothecin results in increased expression of H2AX protein]]; ERCC4 protein promotes the reaction [veliparib promotes the reaction [Camptothecin results in increased expression of H2AX protein]]; ESR1 promotes the reaction [Diethylhexyl Phthalate inhibits the reaction [Camptothecin results in increased expression of H2AX protein modified form]]; H2AX gene mutant form inhibits the reaction [MIR138-1 results in increased susceptibility to Camptothecin]; palbociclib inhibits the reaction [Camptothecin results in increased expression of H2AX protein]; PPP2R2A protein inhibits the reaction [Camptothecin results in increased expression of H2AX protein modified form]; PPP2R5C protein promotes the reaction [Camptothecin results in increased expression of H2AX protein modified form]; PPP2R5E protein inhibits the reaction [Camptothecin results in increased expression of H2AX protein modified form]; TDP1 protein inhibits the reaction [Camptothecin results in increased expression of H2AX protein]; TDP1 protein inhibits the reaction [veliparib promotes the reaction [Camptothecin results in increased expression of H2AX protein]]; veliparib promotes the reaction [Camptothecin results in increased expression of H2AX protein] Camptothecin results in increased expression of H2AX protein; Camptothecin results in increased expression of H2AX protein modified form Camptothecin results in increased phosphorylation of H2AX protein
CTD
PMID:17875725 PMID:21227924 PMID:21646468 PMID:21693595 PMID:22302033 PMID:25269479 PMID:25772433 PMID:26928355 PMID:30720231 PMID:32482060 More...
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
G
Hamp
hepcidin antimicrobial peptide
decreases expression
ISO
Camptothecin results in decreased expression of HAMP mRNA
CTD
PMID:25633564
NCBI chr 1:86,170,926...86,172,865
Ensembl chr 1:86,170,901...86,172,891
G
Hand1
heart and neural crest derivatives expressed 1
increases expression
ISO
Camptothecin results in increased expression of HAND1 mRNA
CTD
PMID:38460933
NCBI chr10:42,006,646...42,009,213
Ensembl chr10:42,006,651...42,009,213
G
Hemk1
HemK methyltransferase family member 1
decreases response to substance
ISO
HEMK1 mRNA results in decreased susceptibility to Camptothecin
CTD
PMID:25269479
NCBI chr 8:107,999,658...108,010,732
Ensembl chr 8:107,999,644...108,010,256
G
Hes6
hes family bHLH transcription factor 6
increases expression
ISO
Camptothecin results in increased expression of HES6 mRNA
CTD
PMID:38460933
NCBI chr 9:92,001,849...92,003,562
Ensembl chr 9:92,001,841...92,003,559
G
Hic1
HIC ZBTB transcriptional repressor 1
increases expression
ISO
Camptothecin results in increased expression of HIC1 mRNA
CTD
PMID:38460933
NCBI chr10:60,014,520...60,019,475
Ensembl chr10:60,011,528...60,019,475
G
Hist2h2be
histone cluster 2 H2B family member E
increases expression
ISO
Camptothecin results in increased expression of HIST2H2BE mRNA
CTD
PMID:38460933
NCBI chr 2:183,780,583...183,783,030
G
Hnrnpc
heterogeneous nuclear ribonucleoprotein C
multiple interactions
ISO
[HNRNPC protein binds to HNRNPC protein alternative form] which results in decreased susceptibility to Camptothecin
CTD
PMID:16960656
NCBI chr15:24,779,593...24,809,213
Ensembl chr15:24,779,450...24,809,183
G
Hoxa1
homeobox A1
decreases response to substance multiple interactions
ISO
HOXA1 mRNA results in decreased susceptibility to Camptothecin Camptothecin inhibits the reaction [Vitamin A results in increased expression of HOXA1]
CTD
PMID:25269479 PMID:26820057
NCBI chr 4:81,255,814...81,258,587
Ensembl chr 4:81,255,883...81,258,504
G
Hoxb13
homeo box B13
increases expression
ISO
Camptothecin results in increased expression of HOXB13 mRNA
CTD
PMID:38460933
NCBI chr10:81,160,498...81,162,777
Ensembl chr10:81,160,498...81,162,777
G
Hoxc13
homeobox C13
increases expression
ISO
Camptothecin results in increased expression of HOXC13 mRNA
CTD
PMID:38460933
NCBI chr 7:134,058,640...134,065,479
Ensembl chr 7:134,058,640...134,064,800
G
Hs3st6
heparan sulfate-glucosamine 3-sulfotransferase 6
increases expression
ISO
Camptothecin results in increased expression of HS3ST6 mRNA
CTD
PMID:38460933
NCBI chr10:13,781,999...13,788,133
Ensembl chr10:13,781,993...13,788,133
G
Hspa6l-ps1
heat shock protein family A (Hsp70) member 6 like, pseudogene 1
increases expression
ISO
Camptothecin results in increased expression of HSPA6 mRNA
CTD
PMID:38460933
NCBI chr13:83,273,176...83,274,317
G
Hspb8
heat shock protein family B (small) member 8
increases expression
ISO
Camptothecin results in increased expression of HSPB8 mRNA
CTD
PMID:38460933
NCBI chr12:40,176,405...40,205,002
Ensembl chr12:40,176,532...40,191,185
G
Ibsp
integrin-binding sialoprotein
decreases response to substance
ISO
IBSP mRNA results in decreased susceptibility to Camptothecin
CTD
PMID:25269479
NCBI chr14:5,439,825...5,452,570
Ensembl chr14:5,439,829...5,452,693
G
Ifi35
interferon-induced protein 35
increases expression
ISO
Camptothecin results in increased expression of IFI35 mRNA
CTD
PMID:38460933
NCBI chr10:86,381,023...86,389,279
Ensembl chr10:86,381,010...86,389,952
G
Ifih1
interferon induced with helicase C domain 1
increases expression
ISO
Camptothecin results in increased expression of IFIH1 mRNA
CTD
PMID:38460933
NCBI chr 3:47,228,980...47,275,403
Ensembl chr 3:47,227,364...47,275,456
G
Ifit2
interferon-induced protein with tetratricopeptide repeats 2
increases expression
ISO
Camptothecin results in increased expression of IFIT2 mRNA
CTD
PMID:38460933
NCBI chr 1:232,102,570...232,108,638
Ensembl chr 1:232,102,570...232,108,635
G
Ifit3
interferon-induced protein with tetratricopeptide repeats 3
increases expression
ISO
Camptothecin results in increased expression of IFIT3 mRNA
CTD
PMID:38460933
NCBI chr 1:232,114,166...232,119,311
Ensembl chr 1:232,114,166...232,119,307
G
Il1b
interleukin 1 beta
decreases response to substance
ISO
IL1B protein results in decreased susceptibility to Camptothecin
CTD
PMID:16356833
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6r
interleukin 6 receptor
decreases expression
ISO
Camptothecin results in decreased expression of IL6R protein modified form
CTD
PMID:20116850
NCBI chr 2:175,289,157...175,347,719
Ensembl chr 2:175,298,686...175,347,536
G
Ildr2
immunoglobulin-like domain containing receptor 2
increases expression
ISO
Camptothecin results in increased expression of ILDR2 mRNA
CTD
PMID:38460933
NCBI chr13:78,518,770...78,580,627
Ensembl chr13:78,518,802...78,576,924
G
Ina
internexin neuronal intermediate filament protein, alpha
increases expression
ISO
Camptothecin results in increased expression of INA mRNA
CTD
PMID:38460933
NCBI chr 1:245,896,775...245,908,330
Ensembl chr 1:245,896,775...245,908,330
G
Inka1
inka box actin regulator 1
increases expression
ISO
Camptothecin results in increased expression of FAM212A mRNA
CTD
PMID:38460933
NCBI chr 8:108,674,263...108,675,953
Ensembl chr 8:108,674,263...108,675,953
G
Inpp1
inositol polyphosphate-1-phosphatase
increases expression
ISO
Camptothecin results in increased expression of INPP1 mRNA
CTD
PMID:38460933
NCBI chr 9:48,688,037...48,717,793
Ensembl chr 9:48,669,901...48,717,793
G
Inpp5d
inositol polyphosphate-5-phosphatase D
increases expression
ISO
Camptothecin results in increased expression of INPP5D mRNA
CTD
PMID:38460933
NCBI chr 9:88,287,680...88,392,748
Ensembl chr 9:88,287,677...88,392,746
G
Insyn2a
inhibitory synaptic factor 2A
increases expression
ISO
Camptothecin results in increased expression of INSYN2A mRNA
CTD
PMID:38460933
NCBI chr 1:189,697,856...189,753,194
Ensembl chr 1:189,697,878...189,752,922
G
Irf5
interferon regulatory factor 5
increases expression
ISO
Camptothecin results in increased expression of IRF5 mRNA
CTD
PMID:38460933
NCBI chr 4:58,127,577...58,140,665
Ensembl chr 4:58,127,640...58,139,267
G
Isg15
ISG15 ubiquitin-like modifier
increases expression
ISO
Camptothecin results in increased expression of ISG15 mRNA
CTD
PMID:38460933
NCBI chr 5:166,784,148...166,785,435
Ensembl chr 5:166,784,148...166,785,435
G
Isg20
interferon stimulated exonuclease gene 20
increases expression
ISO
Camptothecin results in increased expression of ISG20 mRNA
CTD
PMID:38460933
NCBI chr 1:132,829,303...132,837,027
Ensembl chr 1:132,815,123...132,837,027
G
Itm2a
integral membrane protein 2A
increases expression
ISO
Camptothecin results in increased expression of ITM2A mRNA
CTD
PMID:38460933
NCBI chr X:72,486,383...72,492,344
Ensembl chr X:72,486,381...72,492,363
G
Itpkc
inositol-trisphosphate 3-kinase C
increases expression
ISO
Camptothecin results in increased expression of ITPKC mRNA
CTD
PMID:38460933
NCBI chr 1:82,500,957...82,522,533
Ensembl chr 1:82,500,957...82,522,779
G
Jarid2
jumonji and AT-rich interaction domain containing 2
decreases expression
ISO
Camptothecin results in decreased expression of JARID2 mRNA
CTD
PMID:33770205
NCBI chr17:19,777,487...19,957,696
Ensembl chr17:19,777,266...19,955,690
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
increases expression increases phosphorylation multiple interactions
ISO EXP
Camptothecin results in increased expression of JUN protein Camptothecin results in increased phosphorylation of JUN protein Glutathione inhibits the reaction [Camptothecin results in increased phosphorylation of JUN protein]; MAPK8 protein affects the reaction [Camptothecin results in increased phosphorylation of JUN protein]
CTD
PMID:9751194 PMID:15585644 PMID:30266318 PMID:30885713
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
Kank3
KN motif and ankyrin repeat domains 3
increases expression
ISO
Camptothecin results in increased expression of KANK3 mRNA
CTD
PMID:38460933
NCBI chr 7:14,594,358...14,607,675
Ensembl chr 7:14,594,422...14,607,675
G
Kcnj12
potassium inwardly-rectifying channel, subfamily J, member 12
increases expression
ISO
Camptothecin results in increased expression of KCNJ12 mRNA
CTD
PMID:38460933
NCBI chr10:45,696,621...45,745,528
Ensembl chr10:45,696,849...45,745,492
G
Kcnk2
potassium two pore domain channel subfamily K member 2
decreases response to substance
ISO
KCNK2 mRNA results in decreased susceptibility to Camptothecin
CTD
PMID:25269479
NCBI chr13:100,766,101...100,963,435
Ensembl chr13:100,766,113...100,963,435
G
Kcnk6
potassium two pore domain channel subfamily K member 6
increases expression
ISO
Camptothecin results in increased expression of KCNK6 mRNA
CTD
PMID:38460933
NCBI chr 1:84,525,613...84,533,948
Ensembl chr 1:84,525,590...84,534,677
G
Kcns2
potassium voltage-gated channel, modifier subfamily S, member 2
increases expression
ISO
Camptothecin results in increased expression of KCNS2 mRNA
CTD
PMID:38460933
NCBI chr 7:66,022,352...66,028,422
Ensembl chr 7:66,022,352...66,028,422
G
Kdm6b
lysine demethylase 6B
increases expression
ISO
Camptothecin results in increased expression of KDM6B mRNA
CTD
PMID:38460933
NCBI chr10:54,120,716...54,142,212
Ensembl chr10:54,121,848...54,130,794
G
Kif17
kinesin family member 17
increases expression
ISO
Camptothecin results in increased expression of KIF17 mRNA
CTD
PMID:38460933
NCBI chr 5:150,482,288...150,521,471
Ensembl chr 5:150,481,578...150,519,638
G
Klc3
kinesin light chain 3
increases expression
ISO
Camptothecin results in increased expression of KLC3 mRNA
CTD
PMID:38460933
NCBI chr 1:79,045,842...79,055,809
Ensembl chr 1:79,045,844...79,055,416
G
Klhdc7a
kelch domain containing 7A
increases expression
ISO
Camptothecin results in increased expression of KLHDC7A mRNA
CTD
PMID:38460933
NCBI chr 5:152,218,604...152,224,707
Ensembl chr 5:152,221,033...152,224,551
G
Klhl42
kelch-like family, member 42
increases expression
ISO
Camptothecin results in increased expression of KLHL42 mRNA
CTD
PMID:33770205
NCBI chr 4:179,999,655...180,027,283
Ensembl chr 4:180,004,580...180,027,283
G
Klrg2
killer cell lectin like receptor G2
increases expression
ISO
Camptothecin results in increased expression of KLRG2 mRNA
CTD
PMID:38460933
NCBI chr 4:67,360,216...67,374,867
Ensembl chr 4:67,363,919...67,374,147
G
Krt15
keratin 15
increases expression
ISO
Camptothecin results in increased expression of KRT15 mRNA
CTD
PMID:38460933
NCBI chr10:85,066,797...85,070,614
Ensembl chr10:85,066,802...85,171,799
G
Krt19
keratin 19
increases expression
ISO
Camptothecin results in increased expression of KRT19 mRNA
CTD
PMID:38460933
NCBI chr10:85,075,835...85,080,552
Ensembl chr10:85,066,802...85,171,799
G
Krt32
keratin 32
increases expression
ISO
Camptothecin results in increased expression of KRT32 mRNA
CTD
PMID:38460933
NCBI chr10:85,013,551...85,020,578
Ensembl chr10:85,013,554...85,020,534
G
Krtap3-1
keratin associated protein 3-1
increases expression
ISO
Camptothecin results in increased expression of KRTAP3-1 mRNA
CTD
PMID:38460933
NCBI chr10:84,527,698...84,527,994
Ensembl chr10:84,527,448...84,528,041
G
Lacc1
laccase domain containing 1
increases expression
ISO
Camptothecin results in increased expression of LACC1 mRNA
CTD
PMID:38460933
NCBI chr15:52,390,267...52,407,630
Ensembl chr15:52,395,183...52,407,545
G
Lamc3
laminin subunit gamma 3
increases expression
ISO
Camptothecin results in increased expression of LAMC3 mRNA
CTD
PMID:38460933
NCBI chr 3:15,165,220...15,226,697
Ensembl chr 3:15,165,220...15,226,697
G
Lamp3
lysosomal-associated membrane protein 3
increases expression
ISO
Camptothecin results in increased expression of LAMP3 mRNA
CTD
PMID:38460933
NCBI chr11:81,153,491...81,224,643
Ensembl chr11:81,193,649...81,221,784
G
Lce1f
late cornified envelope 1F
increases expression
ISO
Camptothecin results in increased expression of LCE1F mRNA
CTD
PMID:38460933
NCBI chr 2:178,305,786...178,307,372
Ensembl chr 2:178,305,786...178,307,372
G
Lgals1
galectin 1
decreases expression
ISO
Camptothecin results in decreased expression of LGALS1 mRNA; Camptothecin results in decreased expression of LGALS1 protein
CTD
PMID:19483324
NCBI chr 7:110,485,239...110,488,345
Ensembl chr 7:110,481,392...110,488,345
G
Lhx3
LIM homeobox 3
increases expression
ISO
Camptothecin results in increased expression of LHX3 mRNA
CTD
PMID:38460933
NCBI chr 3:9,026,432...9,035,122
Ensembl chr 3:9,027,425...9,034,480
G
Lhx6
LIM homeobox 6
increases expression
ISO
Camptothecin results in increased expression of LHX6 mRNA
CTD
PMID:38460933
NCBI chr 3:19,432,439...19,456,268
Ensembl chr 3:19,433,494...19,456,061
G
Lipg
lipase G, endothelial type
increases expression
ISO
Camptothecin results in increased expression of LIPG mRNA
CTD
PMID:38460933
NCBI chr18:68,514,923...68,536,105
Ensembl chr18:68,514,923...68,536,260
G
Lpin3
lipin 3
increases expression
ISO
Camptothecin results in increased expression of LPIN3 mRNA
CTD
PMID:38460933
NCBI chr 3:149,533,719...149,558,494
Ensembl chr 3:149,534,051...149,558,327
G
Lrch4
leucine rich repeats and calponin homology domain containing 4
decreases response to substance
ISO
LRCH4 mRNA results in decreased susceptibility to Camptothecin
CTD
PMID:25269479
NCBI chr12:19,057,582...19,072,573
Ensembl chr12:19,057,587...19,068,577
G
Lrp1
LDL receptor related protein 1
increases expression
ISO
Camptothecin results in increased expression of LRP1 mRNA
CTD
PMID:38460933
NCBI chr 7:63,380,325...63,461,029
Ensembl chr 7:63,380,356...63,460,910
G
Mad2l1
mitotic arrest deficient 2 like 1
multiple interactions increases expression
ISO
Camptothecin promotes the reaction [MAD2L1 protein binds to CDC20 protein]; CDKN1A protein affects the reaction [Camptothecin results in increased expression of MAD2L1 protein]; MAD2L1 protein affects the reaction [Camptothecin results in increased expression of and results in increased activity of CDK1 protein]; MAD2L1 protein affects the reaction [Camptothecin results in increased expression of CASP8 protein]; MAD2L1 protein affects the reaction [Camptothecin results in increased expression of CASP9 protein]; MAD2L1 protein affects the reaction [Camptothecin results in increased expression of CCNB1 protein]; MAPK8 protein affects the reaction [Camptothecin results in increased expression of MAD2L1 protein] Camptothecin results in increased expression of MAD2L1 mRNA; Camptothecin results in increased expression of MAD2L1 protein
CTD
PMID:30885713
NCBI chr 4:95,906,692...95,918,885
Ensembl chr 4:95,906,817...95,913,470
G
Maf
MAF bZIP transcription factor
increases expression
ISO
Camptothecin results in increased expression of MAF mRNA
CTD
PMID:38460933
NCBI chr19:43,353,867...43,713,162
Ensembl chr19:43,360,342...43,712,365
G
Mafa
MAF bZIP transcription factor A
increases expression
ISO
Camptothecin results in increased expression of MAFA mRNA
CTD
PMID:38460933
NCBI chr 7:107,432,292...107,435,084
Ensembl chr 7:107,433,605...107,434,690
G
Mageh1
MAGE family member H1
increases expression
ISO
Camptothecin results in increased expression of MAGEH1 mRNA
CTD
PMID:38460933
NCBI chr X:18,350,015...18,351,271
Ensembl chr X:18,349,774...18,351,516
G
Map2k3
mitogen activated protein kinase kinase 3
increases expression
ISO
Camptothecin results in increased expression of MAP2K3 mRNA
CTD
PMID:17374387
NCBI chr10:45,608,145...45,629,492
Ensembl chr10:45,607,163...45,629,492
G
Map3k5
mitogen-activated protein kinase kinase kinase 5
decreases expression
ISO
Camptothecin results in decreased expression of MAP3K5 mRNA
CTD
PMID:17374387
NCBI chr 1:14,685,776...14,904,935
Ensembl chr 1:14,685,492...14,904,800
G
Map3k7
mitogen activated protein kinase kinase kinase 7
decreases response to substance
ISO
MAP3K7 mRNA results in decreased susceptibility to Camptothecin
CTD
PMID:25269479
NCBI chr 5:46,356,973...46,415,597
Ensembl chr 5:46,357,931...46,415,597
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
ISO
[Camptothecin co-treated with Nicotine] results in increased phosphorylation of MAPK1 protein
CTD
PMID:24095863
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
ISO
[Camptothecin co-treated with Nicotine] results in increased phosphorylation of MAPK3 protein
CTD
PMID:24095863
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
increases phosphorylation multiple interactions
ISO
Camptothecin results in increased phosphorylation of MAPK8 protein MAPK8 protein affects the reaction [Camptothecin results in increased activity of SP1 protein]; MAPK8 protein affects the reaction [Camptothecin results in increased expression of CCNB1 protein]; MAPK8 protein affects the reaction [Camptothecin results in increased expression of CDK1 protein]; MAPK8 protein affects the reaction [Camptothecin results in increased expression of MAD2L1 protein]; MAPK8 protein affects the reaction [Camptothecin results in increased phosphorylation of JUN protein]
CTD
PMID:30885713 PMID:31255635
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Mapk9
mitogen-activated protein kinase 9
increases phosphorylation
ISO
Camptothecin results in increased phosphorylation of MAPK9 protein
CTD
PMID:15585644
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
G
Mapkbp1
mitogen activated protein kinase binding protein 1
increases expression
ISO
Camptothecin results in increased expression of MAPKBP1 mRNA
CTD
PMID:38460933
NCBI chr 3:106,947,342...106,998,368
Ensembl chr 3:106,947,827...106,996,199
G
Mapt
microtubule-associated protein tau
decreases expression
ISO
Camptothecin results in decreased expression of MAPT mRNA; Camptothecin results in decreased expression of MAPT protein
CTD
PMID:16930453
NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129
G
Marveld3
MARVEL domain containing 3
increases expression
ISO
Camptothecin results in increased expression of MARVELD3 mRNA
CTD
PMID:38460933
NCBI chr19:37,908,727...37,923,420
Ensembl chr19:37,905,638...37,923,420
G
Mdc1
mediator of DNA damage checkpoint 1
multiple interactions
ISO
[Aminacrine results in decreased phosphorylation of H2AX protein] inhibits the reaction [Camptothecin results in increased activity of and affects the localization of MDC1 protein]; [Propyl Gallate results in decreased phosphorylation of H2AX protein] inhibits the reaction [Camptothecin results in increased activity of and affects the localization of MDC1 protein]; Aminacrine inhibits the reaction [Camptothecin results in increased activity of and affects the localization of MDC1 protein]; Camptothecin results in increased activity of and affects the localization of MDC1 protein; Propyl Gallate inhibits the reaction [Camptothecin results in increased activity of and affects the localization of MDC1 protein]
CTD
PMID:26928355
NCBI chr20:2,893,693...2,912,394
Ensembl chr20:2,895,505...2,910,240
G
Mdm2
MDM2 proto-oncogene
increases expression
ISO
Camptothecin results in increased expression of MDM2 protein
CTD
PMID:17555331
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
G
Metrnl
meteorin-like, glial cell differentiation regulator
increases expression
ISO
Camptothecin results in increased expression of METRNL mRNA
CTD
PMID:38460933
NCBI chr10:106,963,880...106,977,875
Ensembl chr10:106,963,880...106,977,869
G
Mgmt
O-6-methylguanine-DNA methyltransferase
decreases expression
ISO
Camptothecin results in decreased expression of MGMT mRNA
CTD
PMID:18492797
NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756
G
Mib2
MIB E3 ubiquitin protein ligase 2
increases expression
ISO
Camptothecin results in increased expression of MIB2 mRNA
CTD
PMID:38460933
NCBI chr 5:166,243,776...166,259,944
Ensembl chr 5:166,243,776...166,259,650
G
Mir138-1
microRNA 138-1
multiple interactions increases response to substance
ISO
[MIR138-1 results in decreased expression of H2AX] which results in increased susceptibility to Camptothecin; H2AX gene mutant form inhibits the reaction [MIR138-1 results in increased susceptibility to Camptothecin]
CTD
PMID:21693595
NCBI chr 8:122,300,966...122,301,064
Ensembl chr 8:122,300,966...122,301,064
G
Mir145
microRNA 145
increases expression decreases expression
ISO
Camptothecin results in increased expression of MIR145 mRNA Camptothecin results in decreased expression of MIR145 mRNA
CTD
PMID:24726431
NCBI chr18:55,099,640...55,099,727
Ensembl chr18:55,099,640...55,099,727
G
Mir34a
microRNA 34a
increases expression
ISO
Camptothecin results in increased expression of MIR34A mRNA
CTD
PMID:24726431
NCBI chr 5:160,533,002...160,533,103
Ensembl chr 5:160,533,002...160,533,103
G
Mknk2
MAPK interacting serine/threonine kinase 2
increases expression
ISO
Camptothecin results in increased expression of MKNK2 mRNA
CTD
PMID:38460933
NCBI chr 7:9,039,771...9,050,832
Ensembl chr 7:9,039,728...9,050,827
G
Mmp11
matrix metallopeptidase 11
increases expression
ISO
Camptothecin results in increased expression of MMP11 mRNA
CTD
PMID:38460933
NCBI chr20:12,730,846...12,739,629
Ensembl chr20:12,730,836...12,739,628
G
Mmp9
matrix metallopeptidase 9
decreases response to substance decreases methylation
ISO
MMP9 mRNA results in decreased susceptibility to Camptothecin Camptothecin results in decreased methylation of MMP9 gene
CTD
PMID:25269479 PMID:30720231
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Mr1
major histocompatibility complex, class I-related
increases expression
ISO
Camptothecin results in increased expression of MR1 mRNA
CTD
PMID:38460933
NCBI chr13:67,298,362...67,317,985
Ensembl chr13:67,299,585...67,317,970
G
Mre11
MRE11 homolog, double strand break repair nuclease
decreases expression
ISO
Camptothecin results in decreased expression of MRE11 mRNA
CTD
PMID:24792648
NCBI chr 8:11,618,876...11,680,451
Ensembl chr 8:11,632,354...11,678,279
G
Mrps33
mitochondrial ribosomal protein S33
increases expression
ISO
Camptothecin results in increased expression of MRPS33 mRNA
CTD
PMID:38460933
NCBI chr 4:68,596,729...68,605,547
Ensembl chr 4:68,596,729...68,605,428
G
Mtmr2
myotubularin related protein 2
decreases response to substance
ISO
MTMR2 mRNA results in decreased susceptibility to Camptothecin
CTD
PMID:25269479
NCBI chr 8:10,617,993...10,670,724
Ensembl chr 8:10,617,993...10,668,172
G
Mtor
mechanistic target of rapamycin kinase
decreases expression
ISO
Camptothecin results in decreased expression of MTOR protein
CTD
PMID:31255635
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
G
Mx1
MX dynamin like GTPase 1
increases expression
ISO
Camptothecin results in increased expression of MX1 mRNA
CTD
PMID:38460933
NCBI chr11:36,799,659...36,825,209
Ensembl chr11:36,799,660...36,823,507
G
Myc
MYC proto-oncogene, bHLH transcription factor
increases expression affects localization multiple interactions
ISO
Camptothecin results in increased expression of MYC mRNA Camptothecin affects the localization of MYC protein Camptothecin results in increased expression of and results in increased activity of MYC protein; MYC protein affects the reaction [Camptothecin results in increased expression of ATF4 protein]; MYC protein affects the reaction [Camptothecin results in increased expression of DDIT3 protein]; MYC protein affects the reaction [Camptothecin results in increased phosphorylation of EIF2AK3 protein]; MYC protein affects the reaction [Camptothecin results in increased phosphorylation of EIF2S1 protein]; TERT protein affects the reaction [Camptothecin results in increased expression of MYC protein]
CTD
PMID:30266318 PMID:30851366
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Myo1e
myosin IE
decreases expression
ISO
Camptothecin results in decreased expression of MYO1E mRNA
CTD
PMID:33770205
NCBI chr 8:70,887,934...71,080,180
Ensembl chr 8:70,887,870...71,080,169
G
Nadsyn1
NAD synthetase 1
increases expression
ISO
Camptothecin results in increased expression of NADSYN1 mRNA
CTD
PMID:38460933
NCBI chr 1:198,981,559...199,009,853
Ensembl chr 1:198,981,604...199,009,869
G
Nap1l5
nucleosome assembly protein 1-like 5
increases expression
ISO
Camptothecin results in increased expression of NAP1L5 mRNA
CTD
PMID:38460933
NCBI chr 4:88,022,670...88,024,988
Ensembl chr 4:88,022,569...88,024,654
G
Ncam1
neural cell adhesion molecule 1
decreases response to substance
ISO
NCAM1 mRNA results in decreased susceptibility to Camptothecin
CTD
PMID:25269479
NCBI chr 8:49,865,629...50,165,687
Ensembl chr 8:49,865,633...50,166,014
G
Nck2
NCK adaptor protein 2
decreases expression
ISO
Camptothecin results in decreased expression of NCK2 mRNA
CTD
PMID:17374387
NCBI chr 9:45,713,979...45,840,330
Ensembl chr 9:45,714,883...45,840,307
G
Ncoa1
nuclear receptor coactivator 1
multiple interactions
ISO
Camptothecin inhibits the reaction [Rifampin promotes the reaction [NCOA1 protein binds to NR1I2 protein]]
CTD
PMID:29356861
NCBI chr 6:27,232,609...27,507,992
Ensembl chr 6:27,232,611...27,475,664
G
Ncor2
nuclear receptor co-repressor 2
multiple interactions
ISO
Camptothecin inhibits the reaction [NCOR2 protein binds to NR1I2 protein]
CTD
PMID:29356861
NCBI chr12:31,466,418...31,628,319
Ensembl chr12:31,466,412...31,628,319
G
Ncr3lg1
natural killer cell cytotoxicity receptor 3 ligand 1
increases expression
ISO
Camptothecin results in increased expression of NCR3LG1 mRNA
CTD
PMID:38460933
NCBI chr 1:96,565,664...96,581,825
Ensembl chr 1:96,574,455...96,580,466
G
Ndufc1
NADH:ubiquinone oxidoreductase subunit C1
increases expression
ISO
Camptothecin results in increased expression of NDUFC1 mRNA
CTD
PMID:38460933
NCBI chr 2:135,447,067...135,450,950
Ensembl chr 2:135,447,119...135,450,874
G
Nefl
neurofilament light chain
increases expression
ISO
Camptothecin results in increased expression of NEFL mRNA
CTD
PMID:38460933
NCBI chr15:42,301,920...42,305,793
Ensembl chr15:42,301,916...42,305,793
G
Nefm
neurofilament medium chain
increases expression
ISO
Camptothecin results in increased expression of NEFM mRNA
CTD
PMID:38460933
NCBI chr15:42,360,449...42,365,753
Ensembl chr15:42,360,454...42,365,755
G
Neurl3
neuralized E3 ubiquitin protein ligase 3
increases expression
ISO
Camptothecin results in increased expression of NEURL3 mRNA
CTD
PMID:38460933
NCBI chr 9:38,494,486...38,503,352
Ensembl chr 9:38,494,489...38,502,649
G
Nfe2l2
NFE2 like bZIP transcription factor 2
multiple interactions increases activity
ISO
NFE2L2 protein affects the reaction [Camptothecin results in increased expression of TERT mRNA] Camptothecin results in increased activity of NFE2L2 protein
CTD
PMID:30851366
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Ninj1
ninjurin 1
increases expression
ISO
Camptothecin results in increased expression of NINJ1 mRNA
CTD
PMID:38460933
NCBI chr17:15,452,804...15,461,684
Ensembl chr17:15,452,813...15,461,704
G
Nipal1
NIPA-like domain containing 1
increases expression
ISO
Camptothecin results in increased expression of NIPAL1 mRNA
CTD
PMID:38460933
NCBI chr14:35,537,641...35,561,656
Ensembl chr14:35,540,324...35,561,659
G
Nkd2
NKD inhibitor of WNT signaling pathway 2
increases expression
ISO
Camptothecin results in increased expression of NKD2 mRNA
CTD
PMID:38460933
NCBI chr 1:29,442,898...29,470,839
Ensembl chr 1:29,441,328...29,470,821
G
Nkx2-5
NK2 homeobox 5
increases expression
ISO
Camptothecin results in increased expression of NKX2-5 mRNA
CTD
PMID:38460933
NCBI chr10:16,340,428...16,347,004
Ensembl chr10:16,344,159...16,346,934
G
Nlrx1
NLR family member X1
increases expression
ISO
Camptothecin results in increased expression of NLRX1 mRNA
CTD
PMID:38460933
NCBI chr 8:44,588,476...44,606,678
Ensembl chr 8:44,590,048...44,606,484
G
Npas1
neuronal PAS domain protein 1
increases expression
ISO
Camptothecin results in increased expression of NPAS1 mRNA
CTD
PMID:38460933
NCBI chr 1:77,167,375...77,187,887
Ensembl chr 1:77,167,381...77,186,762
G
Npl
N-acetylneuraminate pyruvate lyase
increases expression
ISO
Camptothecin results in increased expression of NPL mRNA
CTD
PMID:38460933
NCBI chr13:65,655,099...65,697,464
Ensembl chr13:65,655,118...65,697,372
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
multiple interactions
ISO
Camptothecin inhibits the reaction [NCOR2 protein binds to NR1I2 protein]; Camptothecin inhibits the reaction [Rifampin promotes the reaction [NCOA1 protein binds to NR1I2 protein]]; Camptothecin inhibits the reaction [Rifampin results in increased activity of NR1I2 protein]
CTD
PMID:29356861
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
G
Nr4a1
nuclear receptor subfamily 4, group A, member 1
increases expression
ISO
Camptothecin results in increased expression of NR4A1 mRNA
CTD
PMID:38460933
NCBI chr 7:132,368,399...132,389,300
Ensembl chr 7:132,374,840...132,389,297
G
Nsg1
neuronal vesicle trafficking associated 1
increases expression
ISO
Camptothecin results in increased expression of NSG1 mRNA
CTD
PMID:38460933
NCBI chr14:72,648,771...72,670,521
Ensembl chr14:72,648,741...72,670,514
G
Ntn1
netrin 1
increases expression
ISO
Camptothecin results in increased expression of NTN1 mRNA
CTD
PMID:38460933
NCBI chr10:52,899,933...53,098,591
Ensembl chr10:52,899,934...53,085,326
G
Oas1a
2'-5' oligoadenylate synthetase 1A
increases expression
ISO
Camptothecin results in increased expression of OAS1 mRNA
CTD
PMID:38460933
NCBI chr12:35,669,798...35,680,505
Ensembl chr12:35,669,801...35,680,517
G
Oprl1
opioid related nociceptin receptor 1
increases expression
ISO
Camptothecin results in increased expression of OPRL1 mRNA
CTD
PMID:38460933
NCBI chr 3:168,831,934...168,839,920
Ensembl chr 3:168,834,003...168,839,920
G
Or1a1b
olfactory receptor family 1 subfamily A member 1B
decreases response to substance
ISO
OR1A2 mRNA results in decreased susceptibility to Camptothecin
CTD
PMID:25269479
NCBI chr10:59,070,239...59,071,183
Ensembl chr10:59,069,404...59,075,457
G
Or7c70
olfactory receptor family 7 subfamily C member 70
decreases response to substance
ISO
OR7C2 mRNA results in decreased susceptibility to Camptothecin
CTD
PMID:25269479
NCBI chr 7:10,810,624...10,811,586
Ensembl chr 7:10,799,830...10,813,059
G
Otulinl
OTU deubiquitinase with linear linkage specificity like
increases expression
ISO
Camptothecin results in increased expression of FAM105A mRNA
CTD
PMID:38460933
NCBI chr 2:78,405,994...78,433,860
Ensembl chr 2:78,408,593...78,433,838
G
Palmd
palmdelphin
increases expression
ISO
Camptothecin results in increased expression of PALMD mRNA
CTD
PMID:38460933
NCBI chr 2:204,889,526...204,941,355
Ensembl chr 2:204,889,533...204,941,519
G
Pank1
pantothenate kinase 1
increases expression
ISO
Camptothecin results in increased expression of PANK1 mRNA
CTD
PMID:38460933
NCBI chr 1:232,324,718...232,395,445
Ensembl chr 1:232,328,430...232,396,829
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions increases cleavage decreases response to substance affects response to substance
ISO EXP
6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Camptothecin results in increased cleavage of PARP1 protein]; 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide promotes the reaction [Camptothecin results in increased cleavage of PARP1 protein]; benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [Camptothecin results in increased cleavage of PARP1 protein]; Camptothecin results in increased ADP-ribosylation of and results in increased degradation of PARP1 protein; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Camptothecin results in increased ADP-ribosylation of and results in increased degradation of PARP1 protein]; Nicotine inhibits the reaction [Camptothecin results in increased cleavage of PARP1 protein]; PARP1 protein promotes the reaction [Camptothecin results in increased abundance of Poly Adenosine Diphosphate Ribose]; RBL2 protein inhibits the reaction [Camptothecin results in increased cleavage of PARP1 protein]; THBS1 protein inhibits the reaction [Camptothecin results in increased cleavage of PARP1 protein]; XRCC1 protein affects the reaction [PARP1 protein affects the susceptibility to Camptothecin] [Camptothecin co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased cleavage of PARP1 protein; [veliparib results in decreased activity of PARP1 protein] which results in increased susceptibility to Camptothecin Tetrachlorodibenzodioxin promotes the reaction [Camptothecin results in increased cleavage of PARP1 protein] PARP1 results in decreased susceptibility to Camptothecin
CTD
PMID:11741290 PMID:15585644 PMID:16962673 PMID:18506790 PMID:19559722 PMID:22158865 PMID:23376119 PMID:24095863 PMID:24726431 PMID:24792648 PMID:24823293 PMID:25412314 PMID:25449198 PMID:25843524 PMID:27694308 PMID:29384525 PMID:31255635 PMID:35778544 More...
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Pax9
paired box 9
increases expression
ISO
Camptothecin results in increased expression of PAX9 mRNA
CTD
PMID:38460933
NCBI chr 6:74,186,749...74,203,508
Ensembl chr 6:74,182,568...74,203,506
G
Pde2a
phosphodiesterase 2A
increases expression
ISO
Camptothecin results in increased expression of PDE2A mRNA
CTD
PMID:38460933
NCBI chr 1:155,823,590...155,915,434
Ensembl chr 1:155,813,180...155,915,434
G
Pgf
placental growth factor
increases expression
ISO
Camptothecin results in increased expression of PGF mRNA
CTD
PMID:38460933
NCBI chr 6:104,816,102...104,826,685
Ensembl chr 6:104,816,104...104,826,685
G
Pgr
progesterone receptor
multiple interactions
ISO
Camptothecin binds to and results in decreased activity of PGR protein
CTD
PMID:25752796
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
G
Pi4k2a
phosphatidylinositol 4-kinase type 2 alpha
increases expression
ISO
Camptothecin results in increased expression of PI4K2A mRNA
CTD
PMID:38460933
NCBI chr 1:240,902,804...240,929,234
Ensembl chr 1:240,902,855...240,929,337
G
Pik3ap1
phosphoinositide-3-kinase adaptor protein 1
increases expression
ISO
Camptothecin results in increased expression of PIK3AP1 mRNA
CTD
PMID:38460933
NCBI chr 1:240,090,854...240,245,007
Ensembl chr 1:240,093,065...240,204,828
G
Pik3ip1
phosphoinositide-3-kinase interacting protein 1
increases expression
ISO
Camptothecin results in increased expression of PIK3IP1 mRNA
CTD
PMID:38460933
NCBI chr14:78,204,668...78,216,616
Ensembl chr14:78,204,053...78,216,608
G
Pim2
Pim-2 proto-oncogene, serine/threonine kinase
increases expression
ISO
Camptothecin results in increased expression of PIM2 mRNA
CTD
PMID:38460933
NCBI chr X:14,617,582...14,622,851
Ensembl chr X:14,617,582...14,622,851
G
Pla2g4c
phospholipase A2 group IVC
increases expression
ISO
Camptothecin results in increased expression of PLA2G4C mRNA
CTD
PMID:38460933
NCBI chr 1:74,237,714...74,275,757
Ensembl chr 1:74,236,211...74,274,656
G
Plcd1
phospholipase C, delta 1
increases expression
ISO
Camptothecin results in increased expression of PLCD1 mRNA
CTD
PMID:38460933
NCBI chr 8:118,795,196...118,818,186
Ensembl chr 8:118,795,201...118,818,186
G
Plekha4
pleckstrin homology domain containing A4
increases expression
ISO
Camptothecin results in increased expression of PLEKHA4 mRNA
CTD
PMID:38460933
NCBI chr 1:96,005,824...96,028,826
Ensembl chr 1:96,006,000...96,028,826
G
Plekhb1
pleckstrin homology domain containing B1
increases expression
ISO
Camptothecin results in increased expression of PLEKHB1 mRNA
CTD
PMID:38460933
NCBI chr 1:154,998,798...155,013,094
Ensembl chr 1:154,998,800...155,016,142
G
Plin2
perilipin 2
increases expression
ISO
Camptothecin results in increased expression of PLIN2 mRNA
CTD
PMID:38460933
NCBI chr 5:101,156,648...101,211,738
Ensembl chr 5:101,154,411...101,242,319
G
Plk3
polo-like kinase 3
increases expression
ISO
Camptothecin results in increased expression of PLK3 mRNA
CTD
PMID:17374387 PMID:38460933
NCBI chr 5:130,607,142...130,612,317
Ensembl chr 5:130,607,142...130,612,317
G
Pmaip1
phorbol-12-myristate-13-acetate-induced protein 1
increases expression
ISO
Camptothecin results in increased expression of PMAIP1 mRNA
CTD
PMID:38460933
NCBI chr18:59,986,020...59,992,434
Ensembl chr18:59,986,017...59,992,429
G
Podnl1
podocan-like 1
increases expression
ISO
Camptothecin results in increased expression of PODNL1 mRNA
CTD
PMID:38460933
NCBI chr19:24,027,261...24,033,867
Ensembl chr19:24,027,297...24,033,846
G
Ppm1d
protein phosphatase, Mg2+/Mn2+ dependent, 1D
increases expression
ISO
Camptothecin results in increased expression of PPM1D mRNA
CTD
PMID:38460933
NCBI chr10:70,172,603...70,208,607
Ensembl chr10:70,172,603...70,208,607
G
Ppp1r14c
protein phosphatase 1, regulatory (inhibitor) subunit 14c
increases expression
ISO
Camptothecin results in increased expression of PPP1R14C mRNA
CTD
PMID:38460933
NCBI chr 1:39,773,403...39,886,970
Ensembl chr 1:39,773,403...39,886,956
G
Ppp1r16b
protein phosphatase 1, regulatory subunit 16B
decreases response to substance
ISO
PPP1R16B mRNA results in decreased susceptibility to Camptothecin
CTD
PMID:25269479
NCBI chr 3:147,323,652...147,419,658
Ensembl chr 3:147,324,126...147,418,937
G
Ppp1r1b
protein phosphatase 1, regulatory (inhibitor) subunit 1B
decreases response to substance
ISO
PPP1R1B protein alternative form results in decreased susceptibility to Camptothecin; PPP1R1B protein results in decreased susceptibility to Camptothecin
CTD
PMID:16061638
NCBI chr10:83,347,731...83,356,775
Ensembl chr10:83,347,731...83,356,775
G
Ppp1r3c
protein phosphatase 1, regulatory subunit 3C
increases expression
ISO
Camptothecin results in increased expression of PPP1R3C mRNA
CTD
PMID:38460933
NCBI chr 1:234,460,958...234,465,961
Ensembl chr 1:234,460,652...234,465,961
G
Ppp1r3g
protein phosphatase 1, regulatory subunit 3G
increases expression
ISO
Camptothecin results in increased expression of PPP1R3G mRNA
CTD
PMID:38460933
NCBI chr17:28,874,956...28,878,288
Ensembl chr17:28,876,482...28,877,525
G
Ppp2ca
protein phosphatase 2 catalytic subunit alpha
multiple interactions
ISO
Camptothecin affects the localization of [PPP2R5E protein binds to PPP2CA protein]
CTD
PMID:25772433
NCBI chr10:36,358,110...36,377,864
Ensembl chr10:36,358,101...36,377,862
G
Ppp2r1a
protein phosphatase 2 scaffold subunit A alpha
affects localization decreases response to substance
ISO
Camptothecin affects the localization of PPP2R1A protein PPP2R1A mRNA results in decreased susceptibility to Camptothecin
CTD
PMID:25269479 PMID:25772433
NCBI chr 1:60,540,223...60,559,467
Ensembl chr 1:60,540,194...60,560,129
G
Ppp2r2a
protein phosphatase 2, regulatory subunit B, alpha
multiple interactions decreases response to substance
ISO
PPP2R2A protein inhibits the reaction [Camptothecin results in increased expression of H2AX protein modified form] PPP2R2A protein results in decreased susceptibility to Camptothecin
CTD
PMID:25772433
NCBI chr15:41,204,659...41,263,924
Ensembl chr15:41,204,200...41,263,924
G
Ppp2r5c
protein phosphatase 2, regulatory subunit B', gamma
multiple interactions increases response to substance
ISO
PPP2R5C protein promotes the reaction [Camptothecin results in increased expression of H2AX protein modified form] PPP2R5C protein results in increased susceptibility to Camptothecin
CTD
PMID:25772433
NCBI chr 6:129,461,689...129,598,344
Ensembl chr 6:129,461,648...129,598,346
G
Ppp2r5e
protein phosphatase 2 regulatory subunit B', epsilon
multiple interactions decreases response to substance
ISO
Camptothecin affects the localization of [PPP2R5E protein binds to PPP2CA protein]; PPP2R5E protein inhibits the reaction [Camptothecin results in increased expression of H2AX protein modified form] PPP2R5E protein results in decreased susceptibility to Camptothecin
CTD
PMID:25772433
NCBI chr 6:94,168,846...94,317,872
Ensembl chr 6:94,168,846...94,317,872
G
Prc1
protein regulator of cytokinesis 1
decreases expression
ISO
Camptothecin results in decreased expression of PRC1 mRNA
CTD
PMID:17374387
NCBI chr 1:134,250,086...134,271,765
Ensembl chr 1:134,250,081...134,271,765
G
Prdm13
PR/SET domain 13
increases expression
ISO
Camptothecin results in increased expression of PRDM13 mRNA
CTD
PMID:38460933
NCBI chr 5:35,220,815...35,232,866
Ensembl chr 5:35,225,435...35,232,881
G
Prkab1
protein kinase AMP-activated non-catalytic subunit beta 1
increases expression
ISO
Camptothecin results in increased expression of PRKAB1 mRNA
CTD
PMID:38460933
NCBI chr12:40,588,140...40,598,673
Ensembl chr12:40,588,211...40,598,661
G
Prodh
proline dehydrogenase
increases expression
ISO
Camptothecin results in increased expression of PRODH mRNA
CTD
PMID:38460933
NCBI chr11:82,910,043...82,927,305
Ensembl chr11:82,910,137...82,927,305
G
Prrt1
proline-rich transmembrane protein 1
increases expression
ISO
Camptothecin results in increased expression of PRRT1 mRNA
CTD
PMID:38460933
NCBI chr20:4,117,957...4,121,643
Ensembl chr20:4,117,957...4,121,600
G
Prss27
serine protease 27
increases expression
ISO
Camptothecin results in increased expression of PRSS27 mRNA
CTD
PMID:38460933
NCBI chr10:13,069,959...13,077,322
Ensembl chr10:13,069,959...13,077,322
G
Prss35
serine protease 35
increases expression
ISO
Camptothecin results in increased expression of PRSS35 mRNA
CTD
PMID:38460933
NCBI chr 8:87,714,449...87,731,009
Ensembl chr 8:87,714,966...87,731,009
G
Prss57
serine protease 57
increases expression
ISO
Camptothecin results in increased expression of PRSS57 mRNA
CTD
PMID:38460933
NCBI chr 7:9,915,667...9,922,996
Ensembl chr 7:9,917,484...9,922,922
G
Psd3
pleckstrin and Sec7 domain containing 3
decreases expression
ISO
Camptothecin results in decreased expression of PSD3 mRNA
CTD
PMID:33770205
NCBI chr16:21,465,643...22,035,846
Ensembl chr16:21,465,639...22,034,547
G
Ptafr
platelet-activating factor receptor
increases expression
ISO
Camptothecin results in increased expression of PTAFR mRNA
CTD
PMID:38460933
NCBI chr 5:144,765,770...144,795,057
Ensembl chr 5:144,765,976...144,795,251
G
Ptar1
protein prenyltransferase alpha subunit repeat containing 1
decreases response to substance
ISO
PTAR1 mRNA results in decreased susceptibility to Camptothecin
CTD
PMID:25269479
NCBI chr 1:221,283,306...221,326,861
Ensembl chr 1:221,283,415...221,327,073
G
Pten
phosphatase and tensin homolog
multiple interactions
ISO
Camptothecin results in decreased expression of and results in decreased phosphorylation of PTEN protein
CTD
PMID:30885713
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
G
Ptgs2
prostaglandin-endoperoxide synthase 2
increases expression
ISO
Camptothecin results in increased expression of PTGS2 mRNA
CTD
PMID:38460933
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Ptp4a3
protein tyrosine phosphatase 4A3
increases expression
ISO
Camptothecin results in increased expression of PTP4A3 mRNA
CTD
PMID:38460933
NCBI chr 7:105,650,640...105,660,921
Ensembl chr 7:105,628,029...105,660,919
G
Ptpro
protein tyrosine phosphatase, receptor type, O
decreases response to substance
ISO
PTPRO mRNA results in decreased susceptibility to Camptothecin
CTD
PMID:25269479
NCBI chr 4:170,164,071...170,374,790
Ensembl chr 4:170,164,431...170,374,771
G
Rab37
RAB37, member RAS oncogene family
increases expression
ISO
Camptothecin results in increased expression of RAB37 mRNA
CTD
PMID:38460933
NCBI chr10:100,334,639...100,401,974
Ensembl chr10:100,334,216...100,401,474
G
Rad50
RAD50 double strand break repair protein
decreases expression
ISO
Camptothecin results in decreased expression of RAD50 mRNA
CTD
PMID:24792648
NCBI chr10:37,809,353...37,861,309
Ensembl chr10:37,808,726...37,861,396
G
Rad51
RAD51 recombinase
decreases expression
ISO
Camptothecin results in decreased expression of RAD51 mRNA; Camptothecin results in decreased expression of RAD51 protein
CTD
PMID:10344722 PMID:24792648
NCBI chr 3:106,099,753...106,125,038
Ensembl chr 3:106,100,381...106,125,035
G
Rad51c
RAD51 paralog C
increases response to substance
ISO
RAD51C gene mutant form results in increased susceptibility to Camptothecin
CTD
PMID:20400963
NCBI chr10:72,205,032...72,231,643
Ensembl chr10:72,205,032...72,231,248
G
Rara
retinoic acid receptor, alpha
increases methylation
ISO
Camptothecin results in increased methylation of RARA gene
CTD
PMID:30720231
NCBI chr10:83,883,490...83,928,932
Ensembl chr10:83,893,384...83,928,142
G
Rasal1
RAS protein activator like 1
increases expression
ISO
Camptothecin results in increased expression of RASAL1 mRNA
CTD
PMID:38460933
NCBI chr12:35,881,269...35,913,727
Ensembl chr12:35,881,270...35,913,727
G
Rasd1
ras related dexamethasone induced 1
increases expression
ISO
Camptothecin results in increased expression of RASD1 mRNA
CTD
PMID:38460933
NCBI chr10:44,766,451...44,775,773
Ensembl chr10:44,766,455...44,768,186
G
Rb1
RB transcriptional corepressor 1
increases phosphorylation affects response to substance
ISO
Camptothecin results in increased phosphorylation of RB1 protein RB1 protein affects the susceptibility to Camptothecin
CTD
PMID:14647467 PMID:14704340 PMID:15064736 PMID:15585644
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
G
Rbl1
RB transcriptional corepressor like 1
decreases expression
ISO
Camptothecin results in decreased expression of RBL1 protein
CTD
PMID:15585644
NCBI chr 3:145,806,160...145,869,434
Ensembl chr 3:145,807,095...145,869,330
G
Rbl2
RB transcriptional corepressor like 2
multiple interactions decreases response to substance
ISO
RBL2 protein inhibits the reaction [Camptothecin results in increased cleavage of PARP1 protein] RBL2 protein results in decreased susceptibility to Camptothecin
CTD
PMID:15585644
NCBI chr19:15,876,852...15,923,632
Ensembl chr19:15,876,853...15,923,572
G
Rcor2
REST corepressor 2
increases expression
ISO
Camptothecin results in increased expression of RCOR2 mRNA
CTD
PMID:38460933
NCBI chr 1:204,453,403...204,461,403
Ensembl chr 1:204,454,360...204,460,838
G
Reep2
receptor accessory protein 2
increases expression
ISO
Camptothecin results in increased expression of REEP2 mRNA
CTD
PMID:38460933
NCBI chr18:26,438,130...26,447,165
Ensembl chr18:26,438,346...26,447,161
G
Rela
RELA proto-oncogene, NF-kB subunit
increases response to substance multiple interactions
ISO EXP
RELA results in increased susceptibility to Camptothecin Camptothecin inhibits the reaction [RELA protein binds to CREBBP protein]; pifithrin inhibits the reaction [Camptothecin inhibits the reaction [RELA protein binds to CREBBP protein]] Camptothecin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] affects the localization of and results in increased phosphorylation of RELA protein] Camptothecin results in increased expression of and results in decreased phosphorylation of RELA protein; Diethylhexyl Phthalate inhibits the reaction [Camptothecin results in decreased phosphorylation of RELA protein]; Diethylhexyl Phthalate promotes the reaction [Camptothecin results in increased expression of RELA protein]
CTD
PMID:13679428 PMID:21737676 PMID:25449198 PMID:36394428
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Ret
ret proto-oncogene
decreases expression
EXP
Camptothecin results in decreased expression of RET protein
CTD
PMID:17555550
NCBI chr 4:151,325,969...151,368,176
Ensembl chr 4:151,326,431...151,368,176
G
Retsat
retinol saturase
increases expression
ISO
Camptothecin results in increased expression of RETSAT mRNA
CTD
PMID:38460933
NCBI chr 4:104,653,306...104,662,069
Ensembl chr 4:104,653,155...104,668,310
G
Rgma
repulsive guidance molecule BMP co-receptor a
increases expression
ISO
Camptothecin results in increased expression of RGMA mRNA
CTD
PMID:38460933
NCBI chr 1:127,128,934...127,172,918
Ensembl chr 1:127,128,934...127,172,918
G
Rgs16
regulator of G-protein signaling 16
increases expression
ISO
Camptothecin results in increased expression of RGS16 mRNA
CTD
PMID:38460933
NCBI chr13:65,887,668...65,892,862
Ensembl chr13:65,887,530...65,892,857
G
Rgs2
regulator of G-protein signaling 2
increases expression
ISO
Camptothecin results in increased expression of RGS2 mRNA
CTD
PMID:38460933
NCBI chr13:55,799,749...55,802,354
Ensembl chr13:55,798,829...55,802,385
G
Rhoc
ras homolog family member C
increases expression
ISO
Camptothecin results in increased expression of RHOC mRNA
CTD
PMID:38460933
NCBI chr 2:192,287,065...192,293,292
Ensembl chr 2:192,287,130...192,295,306
G
Rhod
ras homolog family member D
increases expression
ISO
Camptothecin results in increased expression of RHOD mRNA
CTD
PMID:38460933
NCBI chr 1:201,708,699...201,724,405
Ensembl chr 1:201,708,699...201,722,632
G
Rinl
Ras and Rab interactor-like
increases expression
ISO
Camptothecin results in increased expression of RINL mRNA
CTD
PMID:38460933
NCBI chr 1:84,077,011...84,088,590
Ensembl chr 1:84,077,265...84,088,330
G
Rnasel
ribonuclease L
increases expression
ISO
Camptothecin results in increased expression of RNASEL mRNA
CTD
PMID:38460933
NCBI chr13:65,894,990...65,910,354
Ensembl chr13:65,901,459...65,908,704
G
Rnf144b
ring finger protein 144B
increases expression
ISO
Camptothecin results in increased expression of RNF144B mRNA
CTD
PMID:38460933
NCBI chr17:17,431,271...17,580,687
Ensembl chr17:17,432,786...17,562,760
G
Rnf31
ring finger protein 31
decreases response to substance
ISO
RNF31 mRNA results in decreased susceptibility to Camptothecin
CTD
PMID:25269479
NCBI chr15:29,083,047...29,095,328
Ensembl chr15:29,083,631...29,101,915
G
Rom1
retinal outer segment membrane protein 1
increases expression
ISO
Camptothecin results in increased expression of ROM1 mRNA
CTD
PMID:38460933
NCBI chr 1:205,824,050...205,826,058
Ensembl chr 1:205,824,052...205,826,175
G
Rpgrip1
RPGR interacting protein 1
increases expression
ISO
Camptothecin results in increased expression of RPGRIP1 mRNA
CTD
PMID:38460933
NCBI chr15:24,814,576...24,867,522
Ensembl chr15:24,814,614...24,868,605
G
Rpl13a
ribosomal protein L13A
increases expression
ISO
Camptothecin results in increased expression of RPL13A mRNA
CTD
PMID:38460933
NCBI chr 1:95,609,374...95,612,557
Ensembl chr 1:95,609,370...95,620,463
G
Rps4x
ribosomal protein S4, X-linked
increases expression
ISO
Camptothecin results in increased expression of RPS4X mRNA
CTD
PMID:38460933
NCBI chr X:67,298,522...67,302,965
Ensembl chr X:67,298,525...67,303,019 Ensembl chr 4:67,298,525...67,303,019
G
Rps6
ribosomal protein S6
increases expression
ISO
Camptothecin results in increased expression of RPS6 protein modified form
CTD
PMID:29384525
NCBI chr 5:101,371,716...101,374,576
Ensembl chr 5:101,371,136...101,374,602 Ensembl chr 5:101,371,136...101,374,602
G
Rrad
RRAD, Ras related glycolysis inhibitor and calcium channel regulator
increases expression
ISO
Camptothecin results in increased expression of RRAD mRNA
CTD
PMID:38460933
NCBI chr19:354,184...357,424
Ensembl chr19:354,198...357,417
G
Rrm2
ribonucleotide reductase regulatory subunit M2
multiple interactions increases expression
ISO
2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [Camptothecin results in increased expression of RRM2 protein]; 7-hydroxystaurosporine inhibits the reaction [Camptothecin results in increased expression of RRM2 mRNA]; 7-hydroxystaurosporine inhibits the reaction [Camptothecin results in increased expression of RRM2 protein]; Caffeine inhibits the reaction [Camptothecin results in increased expression of RRM2 mRNA]; Caffeine inhibits the reaction [Camptothecin results in increased expression of RRM2 protein]; E2F1 protein promotes the reaction [Camptothecin results in increased expression of RRM2 protein] Camptothecin results in increased expression of RRM2 mRNA; Camptothecin results in increased expression of RRM2 protein
CTD
PMID:22403396
NCBI chr 6:41,339,858...41,346,774
Ensembl chr 6:41,340,557...41,346,773
G
Rrm2b
ribonucleotide reductase regulatory TP53 inducible subunit M2B
increases expression
ISO
Camptothecin results in increased expression of RRM2B mRNA
CTD
PMID:38460933
NCBI chr 7:69,077,024...69,108,742
Ensembl chr 7:69,078,291...69,108,633
G
Rsph1
radial spoke head component 1
increases expression
ISO
Camptothecin results in increased expression of RSPH1 mRNA
CTD
PMID:38460933
NCBI chr20:9,341,910...9,360,640
Ensembl chr20:9,341,913...9,360,640
G
Rundc3a
RUN domain containing 3A
increases expression
ISO
Camptothecin results in increased expression of RUNDC3A mRNA
CTD
PMID:38460933
NCBI chr10:87,352,624...87,361,767
Ensembl chr10:87,352,646...87,361,765
G
Rwdd3
RWD domain containing 3
increases expression
ISO
Camptothecin results in increased expression of RWDD3 mRNA
CTD
PMID:33770205
NCBI chr 2:209,233,622...209,254,842
Ensembl chr 2:209,233,622...209,248,853
G
Sbk1
SH3 domain binding kinase 1
increases expression
ISO
Camptothecin results in increased expression of SBK1 mRNA
CTD
PMID:38460933
NCBI chr 1:180,807,092...180,851,910
Ensembl chr 1:180,807,099...180,851,885
G
Scn3b
sodium voltage-gated channel beta subunit 3
increases expression
ISO
Camptothecin results in increased expression of SCN3B mRNA
CTD
PMID:38460933
NCBI chr 8:40,630,372...40,652,869
Ensembl chr 8:40,630,455...40,652,868
G
Sdc1
syndecan 1
increases expression
ISO
Camptothecin results in increased expression of SDC1 mRNA
CTD
PMID:17374387
NCBI chr 6:31,562,799...31,585,267
Ensembl chr 6:31,562,739...31,585,264
G
Sel1l
SEL1L adaptor subunit of SYVN1 ubiquitin ligase
decreases response to substance
ISO
SEL1L mRNA results in decreased susceptibility to Camptothecin
CTD
PMID:25269479
NCBI chr 6:110,735,450...110,779,695
Ensembl chr 6:110,735,450...110,779,648
G
Septin4
septin 4
increases expression
ISO
Camptothecin results in increased expression of SEPT4 mRNA
CTD
PMID:38460933
NCBI chr10:72,366,729...72,390,764
Ensembl chr10:72,366,873...72,390,768
G
Serpinb5
serpin family B member 5
increases expression
ISO
Camptothecin results in increased expression of SERPINB5 mRNA
CTD
PMID:38460933
NCBI chr13:22,985,557...23,005,756
Ensembl chr13:22,985,557...23,005,756
G
Serpinb7
serpin family B member 7
increases expression
ISO
Camptothecin results in increased expression of SERPINB7 mRNA
CTD
PMID:38460933
NCBI chr13:23,369,830...23,442,205
Ensembl chr13:23,395,671...23,442,205
G
Sertad1
SERTA domain containing 1
increases expression
ISO
Camptothecin results in increased expression of SERTAD1 mRNA
CTD
PMID:38460933
NCBI chr 1:82,775,692...82,778,961
Ensembl chr 1:82,775,252...82,779,091
G
Sesn2
sestrin 2
increases expression
ISO
Camptothecin results in increased expression of SESN2 mRNA
CTD
PMID:38460933
NCBI chr 5:144,702,287...144,721,241
Ensembl chr 5:144,701,530...144,721,260
G
Sfn
stratifin
increases expression
ISO
Camptothecin results in increased expression of SFN mRNA
CTD
PMID:38460933
NCBI chr 5:145,826,722...145,827,994
Ensembl chr 5:145,826,201...145,831,314
G
Sgtb
small glutamine rich tetratricopeptide repeat co-chaperone beta
decreases expression
ISO
Camptothecin results in decreased expression of SGTB mRNA
CTD
PMID:33770205
NCBI chr 2:35,233,045...35,269,527
Ensembl chr 2:35,233,042...35,269,518
G
Sirt1
sirtuin 1
multiple interactions decreases expression
ISO
[SIRT1 mutant form co-treated with Camptothecin] results in increased acetylation of TP53 protein; Camptothecin inhibits the reaction [6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide results in increased expression of SIRT1 protein] Camptothecin results in decreased expression of SIRT1 protein
CTD
PMID:24726431
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
G
Sirt2
sirtuin 2
increases expression
ISO
Camptothecin results in increased expression of SIRT2 mRNA
CTD
PMID:38460933
NCBI chr 1:84,053,883...84,076,975
Ensembl chr 1:84,052,903...84,076,975
G
Sirt4
sirtuin 4
increases expression
ISO
Camptothecin results in increased expression of SIRT4 mRNA
CTD
PMID:38460933
NCBI chr12:41,125,533...41,139,440
Ensembl chr12:41,131,262...41,139,439
G
Slamf7
SLAM family member 7
increases expression
ISO
Camptothecin results in increased expression of SLAMF7 mRNA
CTD
PMID:38460933
NCBI chr13:84,135,656...84,154,528
Ensembl chr13:84,136,899...84,154,105
G
Slc17a7
solute carrier family 17 member 7
increases expression
ISO
Camptothecin results in increased expression of SLC17A7 mRNA
CTD
PMID:38460933
NCBI chr 1:95,649,709...95,661,591
Ensembl chr 1:95,649,745...95,661,588
G
Slc2a12
solute carrier family 2 member 12
increases methylation
ISO
Camptothecin results in increased methylation of SLC2A12 gene
CTD
PMID:30720231
NCBI chr 1:22,803,068...22,862,204
Ensembl chr 1:22,804,418...22,860,971
G
Slc45a4
solute carrier family 45, member 4
increases expression
ISO
Camptothecin results in increased expression of SLC45A4 mRNA
CTD
PMID:38460933
NCBI chr 7:105,478,886...105,550,160
Ensembl chr 7:105,481,792...105,550,170
G
Slc4a11
solute carrier family 4 member 11
increases expression
ISO
Camptothecin results in increased expression of SLC4A11 mRNA
CTD
PMID:38460933
NCBI chr 3:117,900,223...117,912,787
Ensembl chr 3:117,900,223...117,912,674
G
Slfn5
schlafen family member 5
increases expression
ISO
Camptothecin results in increased expression of SLFN5 mRNA
CTD
PMID:38460933
NCBI chr10:67,881,068...67,895,013
Ensembl chr10:67,880,009...67,893,109
G
Smn1
survival of motor neuron 1, telomeric
multiple interactions increases response to substance
ISO
SMN1 mRNA affects the reaction [Camptothecin results in increased activity of CASP3 protein] SMN1 protein results in increased susceptibility to Camptothecin
CTD
PMID:15862279
NCBI chr 2:31,490,018...31,501,065
Ensembl chr 2:31,490,015...31,501,060
G
Smpd3
sphingomyelin phosphodiesterase 3
increases expression
ISO
Camptothecin results in increased expression of SMPD3 mRNA
CTD
PMID:19698806
NCBI chr19:34,162,337...34,245,786
Ensembl chr19:34,162,341...34,245,749
G
Smpdl3b
sphingomyelin phosphodiesterase, acid-like 3B
increases expression
ISO
Camptothecin results in increased expression of SMPDL3B mRNA
CTD
PMID:38460933
NCBI chr 5:144,944,618...144,966,703
Ensembl chr 5:144,944,636...144,966,720
G
Smtnl2
smoothelin-like 2
increases expression
ISO
Camptothecin results in increased expression of SMTNL2 mRNA
CTD
PMID:38460933
NCBI chr10:57,008,322...57,029,505
Ensembl chr10:57,008,327...57,029,505
G
Snai2
snail family transcriptional repressor 2
increases expression
ISO
Camptothecin results in increased expression of SNAI2 mRNA
CTD
PMID:38460933
NCBI chr11:86,182,788...86,186,203
Ensembl chr11:86,181,909...86,186,200
G
Snai3
snail family transcriptional repressor 3
increases expression
ISO
Camptothecin results in increased expression of SNAI3 mRNA
CTD
PMID:38460933
NCBI chr19:50,516,771...50,529,295
Ensembl chr19:50,516,771...50,523,486
G
Snx22
sorting nexin 22
increases expression
ISO
Camptothecin results in increased expression of SNX22 mRNA
CTD
PMID:38460933
NCBI chr 8:66,609,914...66,612,932
Ensembl chr 8:66,609,970...66,612,850
G
Socs1
suppressor of cytokine signaling 1
increases expression
ISO
Camptothecin results in increased expression of SOCS1 mRNA
CTD
PMID:38460933
NCBI chr10:4,882,651...4,884,342
Ensembl chr10:4,882,560...4,884,383
G
Sod1
superoxide dismutase 1
increases expression multiple interactions
ISO
Camptothecin results in increased expression of SOD1 protein Diethylhexyl Phthalate inhibits the reaction [Camptothecin results in increased expression of SOD1 protein]
CTD
PMID:30720231
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Sod2
superoxide dismutase 2
multiple interactions increases expression
ISO
Diethylhexyl Phthalate inhibits the reaction [Camptothecin results in increased expression of SOD2 protein]
CTD
PMID:30720231
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Sorbs1
sorbin and SH3 domain containing 1
increases expression
ISO
Camptothecin results in increased expression of SORBS1 mRNA
CTD
PMID:38460933
NCBI chr 1:239,107,882...239,330,276
Ensembl chr 1:239,108,777...239,330,169
G
Sox11
SRY-box transcription factor 11
increases methylation
ISO
Camptothecin results in increased methylation of SOX11 gene
CTD
PMID:30720231
NCBI chr 6:44,008,333...44,010,354
Ensembl chr 6:44,008,340...44,010,354
G
Sox12
SRY-box transcription factor 12
increases methylation
ISO
Camptothecin results in increased methylation of SOX12 gene
CTD
PMID:30720231
NCBI chr 3:140,859,499...140,860,518
Ensembl chr 3:140,856,579...140,860,975
G
Sox17
SRY-box transcription factor 17
increases methylation
ISO
Camptothecin results in increased methylation of SOX17 gene
CTD
PMID:30720231
NCBI chr 5:15,016,660...15,022,228
Ensembl chr 5:15,016,731...15,022,228
G
Sox3
SRY-box transcription factor 3
increases methylation
ISO
Camptothecin results in increased methylation of SOX3 gene
CTD
PMID:30720231
NCBI chr X:139,308,608...139,310,687
Ensembl chr X:139,309,329...139,310,678
G
Sox4
SRY-box transcription factor 4
increases methylation
ISO
Camptothecin results in increased methylation of SOX4 gene
CTD
PMID:30720231
NCBI chr17:35,667,809...35,672,515
Ensembl chr17:35,667,537...35,673,665
G
Sox8
SRY-box transcription factor 8
increases methylation
ISO
Camptothecin results in increased methylation of SOX8 gene
CTD
PMID:30720231
NCBI chr10:14,584,829...14,589,818
Ensembl chr10:14,584,829...14,589,818
G
Sp1
Sp1 transcription factor
multiple interactions increases activity increases expression
ISO
Acetylcysteine inhibits the reaction [Camptothecin results in increased expression of SP1 mRNA]; Camptothecin results in increased activity of and affects the localization of SP1 protein; Camptothecin results in increased expression of and results in increased activity of SP1 protein; MAPK8 protein affects the reaction [Camptothecin results in increased activity of SP1 protein]; mithramycin A inhibits the reaction [Camptothecin results in increased activity of SP1 protein]; TERT protein affects the reaction [Camptothecin results in increased expression of SP1 protein]
CTD
PMID:11261509 PMID:30851366 PMID:30885713
NCBI chr 7:133,541,302...133,571,961
Ensembl chr 7:133,541,491...133,571,961
G
Sp3
Sp3 transcription factor
increases activity multiple interactions
ISO
Camptothecin results in increased activity of SP3 protein mithramycin A inhibits the reaction [Camptothecin results in increased activity of SP3 protein]
CTD
PMID:11261509
NCBI chr 3:57,811,855...57,857,150
Ensembl chr 3:57,812,075...57,860,342
G
Spata18
spermatogenesis associated 18
increases expression
ISO
Camptothecin results in increased expression of SPATA18 mRNA
CTD
PMID:38460933
NCBI chr14:34,531,931...34,558,671
Ensembl chr14:34,531,061...34,558,687
G
Spata20
spermatogenesis associated 20
increases expression
ISO
Camptothecin results in increased expression of SPATA20 mRNA
CTD
PMID:38460933
NCBI chr10:79,427,525...79,435,472
Ensembl chr10:79,427,528...79,434,368
G
Spint1
serine peptidase inhibitor, Kunitz type 1
increases expression
ISO
Camptothecin results in increased expression of SPINT1 mRNA
CTD
PMID:38460933
NCBI chr 3:106,231,082...106,244,121
Ensembl chr 3:106,231,444...106,244,119
G
Spry1
sprouty RTK signaling antagonist 1
increases expression
ISO
Camptothecin results in increased expression of SPRY1 mRNA
CTD
PMID:38460933
NCBI chr 2:120,557,256...120,561,917
Ensembl chr 2:120,556,706...120,566,189
G
Sqstm1
sequestosome 1
multiple interactions increases degradation
ISO
ATG5 mutant form inhibits the reaction [Camptothecin results in increased degradation of SQSTM1 protein]; Camptothecin inhibits the reaction [Cannabidiol results in increased expression of SQSTM1 mRNA]
CTD
PMID:22927544 PMID:34302491
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
G
Srgap3
SLIT-ROBO Rho GTPase activating protein 3
decreases expression
ISO
Camptothecin results in decreased expression of SRGAP3 mRNA
CTD
PMID:33770205
NCBI chr 4:145,839,369...146,070,556
Ensembl chr 4:145,840,078...146,070,575
G
Srxn1
sulfiredoxin 1
increases expression
ISO
Camptothecin results in increased expression of SRXN1 mRNA
CTD
PMID:22003191
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
G
Sstr5
somatostatin receptor 5
increases expression
ISO
Camptothecin results in increased expression of SSTR5 mRNA
CTD
PMID:38460933
NCBI chr10:14,506,868...14,512,946
Ensembl chr10:14,506,868...14,512,946
G
Stambpl1
STAM binding protein-like 1
increases methylation
ISO
Camptothecin results in increased methylation of STAMBPL1 gene
CTD
PMID:30720231
NCBI chr 1:231,699,620...231,745,034
Ensembl chr 1:231,699,995...231,745,032
G
Stc1
stanniocalcin 1
increases expression
ISO
Camptothecin results in increased expression of STC1 mRNA
CTD
PMID:38460933
NCBI chr15:44,299,591...44,311,695
Ensembl chr15:44,299,621...44,310,264
G
Styxl1
serine/threonine/tyrosine interacting-like 1
decreases response to substance
ISO
STYXL1 mRNA results in decreased susceptibility to Camptothecin
CTD
PMID:25269479
NCBI chr12:20,907,410...20,940,232
Ensembl chr12:20,907,435...20,939,752
G
Suv39h1
SUV39H1 histone lysine methyltransferase
increases expression
ISO
Camptothecin results in increased expression of SUV39H1 mRNA
CTD
PMID:33770205
NCBI chr X:14,421,028...14,433,993
Ensembl chr X:14,421,109...14,433,982
G
Suv39h1-ps1
SUV39H1 histone lysine methyltransferase, pseudogene 1
increases expression
ISO
Camptothecin results in increased expression of SUV39H1 mRNA
CTD
PMID:33770205
NCBI chr X:141,792,589...141,795,257
G
Syk
spleen associated tyrosine kinase
increases expression
ISO
Camptothecin results in increased expression of SYK mRNA
CTD
PMID:38460933
NCBI chr17:12,604,615...12,678,437
Ensembl chr17:12,604,619...12,661,410
G
Synpo2
synaptopodin 2
increases expression
ISO
Camptothecin results in increased expression of SYNPO2 mRNA
CTD
PMID:38460933
NCBI chr 2:211,217,099...211,371,267
Ensembl chr 2:211,216,783...211,371,267
G
Sytl1
synaptotagmin-like 1
increases expression
ISO
Camptothecin results in increased expression of SYTL1 mRNA
CTD
PMID:38460933
NCBI chr 5:145,452,524...145,462,940
Ensembl chr 5:145,422,669...145,462,940
G
Tab2
TGF-beta activated kinase 1/MAP3K7 binding protein 2
decreases response to substance
ISO
TAB2 mRNA results in decreased susceptibility to Camptothecin
CTD
PMID:25269479
NCBI chr 1:2,375,026...2,425,115
Ensembl chr 1:2,375,490...2,424,756
G
Tap1
transporter 1, ATP binding cassette subfamily B member
increases expression
ISO
Camptothecin results in increased expression of TAP1 mRNA
CTD
PMID:17374387 PMID:38460933
NCBI chr20:4,656,262...4,666,634
Ensembl chr20:4,656,263...4,666,901
G
Tax1bp3
Tax1 binding protein 3
increases expression
ISO
Camptothecin results in increased expression of TAX1BP3 mRNA
CTD
PMID:17374387
NCBI chr10:57,795,845...57,800,363
Ensembl chr10:57,795,382...57,800,363
G
Tbc1d16
TBC1 domain family, member 16
decreases expression
ISO
Camptothecin results in decreased expression of TBC1D16 mRNA
CTD
PMID:33770205
NCBI chr10:104,400,963...104,486,698
Ensembl chr10:104,402,398...104,486,670
G
Tbxa2r
thromboxane A2 receptor
increases expression
ISO
Camptothecin results in increased expression of TBXA2R mRNA
CTD
PMID:38460933
NCBI chr 7:8,383,347...8,390,753
Ensembl chr 7:8,383,378...8,388,176
G
Tcea3
transcription elongation factor A3
increases expression
ISO
Camptothecin results in increased expression of TCEA3 mRNA
CTD
PMID:38460933
NCBI chr 5:148,476,941...148,509,452
Ensembl chr 5:148,476,941...148,509,448
G
Tcp11l2
t-complex 11 like 2
increases expression
ISO
Camptothecin results in increased expression of TCP11L2 mRNA
CTD
PMID:38460933
NCBI chr 7:19,150,241...19,185,135
Ensembl chr 7:19,150,252...19,185,095
G
Tdp1
tyrosyl-DNA phosphodiesterase 1
multiple interactions
ISO
TDP1 protein inhibits the reaction [Camptothecin results in increased expression of H2AX protein]; TDP1 protein inhibits the reaction [veliparib promotes the reaction [Camptothecin results in increased expression of H2AX protein]]
CTD
PMID:21227924
NCBI chr 6:119,163,192...119,231,029
Ensembl chr 6:119,163,166...119,231,021
G
Tent5a
terminal nucleotidyltransferase 5A
increases expression
ISO
Camptothecin results in increased expression of FAM46A mRNA
CTD
PMID:38460933
NCBI chr 8:86,222,294...86,229,045
Ensembl chr 8:86,225,357...86,229,045
G
Tert
telomerase reverse transcriptase
increases expression multiple interactions
ISO
Camptothecin results in increased expression of TERT mRNA 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Camptothecin results in increased phosphorylation of TERT protein]; Acetylcysteine inhibits the reaction [Camptothecin results in increased expression of TERT protein]; Camptothecin results in increased expression of and results in increased phosphorylation of TERT protein; Glutathione inhibits the reaction [Camptothecin results in increased expression of TERT protein]; NFE2L2 protein affects the reaction [Camptothecin results in increased expression of TERT mRNA]; TERT protein affects the reaction [Camptothecin results in increased expression of MYC protein]; TERT protein affects the reaction [Camptothecin results in increased expression of SP1 protein]; Wortmannin inhibits the reaction [Camptothecin results in increased phosphorylation of TERT protein]
CTD
PMID:30851366
NCBI chr 1:29,637,213...29,659,561
Ensembl chr 1:29,637,506...29,659,561
G
Tff1
trefoil factor 1
increases expression
ISO
Camptothecin results in increased expression of TFF1 mRNA
CTD
PMID:38460933
NCBI chr20:9,235,736...9,239,597
Ensembl chr20:9,235,736...9,239,597
G
Thbs1
thrombospondin 1
decreases expression multiple interactions decreases secretion
ISO
Camptothecin results in decreased expression of THBS1 mRNA THBS1 protein inhibits the reaction [Camptothecin results in increased activity of CASP3 protein]; THBS1 protein inhibits the reaction [Camptothecin results in increased cleavage of PARP1 protein] Camptothecin results in decreased secretion of THBS1 protein
CTD
PMID:16962673
NCBI chr 3:105,056,293...105,071,445
Ensembl chr 3:105,056,292...105,071,440
G
Thra
thyroid hormone receptor alpha
multiple interactions
ISO
Camptothecin binds to and results in decreased activity of THRA protein
CTD
PMID:25752796
NCBI chr10:83,701,885...83,729,408
Ensembl chr10:83,700,755...83,729,936
G
Thrb
thyroid hormone receptor beta
multiple interactions
ISO
Camptothecin binds to and results in decreased activity of THRB protein
CTD
PMID:25752796
NCBI chr15:7,685,180...8,031,920
Ensembl chr15:7,685,180...7,882,916
G
Thsd1
thrombospondin type 1 domain containing 1
increases expression
ISO
Camptothecin results in increased expression of THSD1 mRNA
CTD
PMID:38460933
NCBI chr16:69,771,408...69,804,844
Ensembl chr16:69,771,408...69,801,504
G
Tincr
TINCR ubiquitin domain containing
increases expression
ISO
Camptothecin results in increased expression of TINCR mRNA
CTD
PMID:38460933
NCBI chr 9:1,387,105...1,389,337
G
Tle6
TLE family member 6, subcortical maternal complex member
increases expression
ISO
Camptothecin results in increased expression of TLE6 mRNA
CTD
PMID:38460933
NCBI chr 7:8,107,050...8,118,639
Ensembl chr 7:8,107,207...8,118,639
G
Tmcc3
transmembrane and coiled-coil domain family 3
increases expression
ISO
Camptothecin results in increased expression of TMCC3 mRNA
CTD
PMID:38460933
NCBI chr 7:28,893,972...29,171,935
Ensembl chr 7:28,893,967...29,171,926
G
Tmem151a
transmembrane protein 151A
increases expression
ISO
Camptothecin results in increased expression of TMEM151A mRNA
CTD
PMID:38460933
NCBI chr 1:202,387,397...202,392,182
Ensembl chr 1:202,388,240...202,392,182
G
Tmem250
transmembrane protein 250
increases expression
ISO
Camptothecin results in increased expression of TMEM250 mRNA
CTD
PMID:33770205
NCBI chr 3:8,962,657...8,966,349
Ensembl chr 3:8,962,657...8,966,349
G
Tmem40
transmembrane protein 40
increases expression
ISO
Camptothecin results in increased expression of TMEM40 mRNA
CTD
PMID:38460933
NCBI chr 4:148,791,509...148,819,287
Ensembl chr 4:148,791,505...148,823,665
G
Tmem47
transmembrane protein 47
increases expression
ISO
Camptothecin results in increased expression of TMEM47 mRNA
CTD
PMID:38460933
NCBI chr X:45,421,405...45,447,900
Ensembl chr X:45,421,405...45,447,900
G
Tmem52
transmembrane protein 52
increases expression
ISO
Camptothecin results in increased expression of TMEM52 mRNA
CTD
PMID:38460933
NCBI chr 5:166,048,669...166,050,423
Ensembl chr 5:166,046,565...166,050,433
G
Tmem63b
transmembrane protein 63B
increases expression
ISO
Camptothecin results in increased expression of TMEM63B mRNA
CTD
PMID:38460933
NCBI chr 9:15,313,867...15,340,722
Ensembl chr 9:15,320,432...15,340,720
G
Tmod2
tropomodulin 2
increases expression
ISO
Camptothecin results in increased expression of TMOD2 mRNA
CTD
PMID:38460933
NCBI chr 8:76,316,736...76,366,003
Ensembl chr 8:76,325,667...76,365,720
G
Tnfrsf14
TNF receptor superfamily member 14
increases expression
ISO
Camptothecin results in increased expression of TNFRSF14 mRNA
CTD
PMID:38460933
NCBI chr 5:165,486,069...165,494,421
Ensembl chr 5:165,484,262...165,493,703
G
Tnfrsf22
tumor necrosis factor receptor superfamily, member 22
increases expression
ISO
Camptothecin results in increased expression of TNFRSF10C mRNA
CTD
PMID:38460933
NCBI chr 1:198,840,452...198,860,713
Ensembl chr 1:198,840,453...198,856,309
G
Tnfsf15
TNF superfamily member 15
increases expression
ISO
Camptothecin results in increased expression of TNFSF15 mRNA
CTD
PMID:38460933
NCBI chr 5:77,134,885...77,156,171
Ensembl chr 5:77,139,878...77,156,228
G
Tnfsf9
TNF superfamily member 9
increases expression
ISO
Camptothecin results in increased expression of TNFSF9 mRNA
CTD
PMID:17374387
NCBI chr 9:1,944,017...1,946,351
Ensembl chr 9:1,944,017...1,946,345
G
Top1
DNA topoisomerase I
multiple interactions decreases response to substance decreases activity
ISO EXP
[Ciprofloxacin co-treated with Camptothecin] results in decreased activity of TOP1 protein; [moxifloxacin co-treated with Camptothecin] results in decreased activity of TOP1 protein TOP1 protein mutant form results in decreased susceptibility to Camptothecin Camptothecin analog results in decreased activity of TOP1 protein; Camptothecin results in decreased activity of TOP1 protein
CTD
PMID:12097280 PMID:18191106 PMID:20600288 PMID:21056033 PMID:21227924 PMID:23376119 PMID:34635930 More...
NCBI chr 3:149,293,469...149,376,618
Ensembl chr 3:149,293,403...149,376,623
G
Tp53
tumor protein p53
multiple interactions increases glutathionylation increases activity increases phosphorylation increases response to substance increases expression decreases acetylation affects response to substance decreases response to substance
ISO EXP
3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole promotes the reaction [Camptothecin results in increased expression of TP53 protein]; [SIRT1 mutant form co-treated with Camptothecin] results in increased acetylation of TP53 protein; Acetylcysteine inhibits the reaction [Camptothecin results in increased expression of TP53 protein modified form]; Camptothecin inhibits the reaction [6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide results in increased acetylation of TP53 protein]; Camptothecin results in increased stability of and results in increased expression of and results in increased phosphorylation of and results in increased activity of TP53 protein; nutlin 3 inhibits the reaction [Camptothecin results in increased expression of TP53 protein]; S-ethyl glutathione inhibits the reaction [Camptothecin results in increased expression of TP53 protein modified form] Camptothecin results in increased glutathionylation of TP53 protein Camptothecin results in increased activity of TP53 protein Camptothecin results in increased phosphorylation of TP53 protein Camptothecin promotes the reaction [TP53 protein binds to CREBBP protein]; pifithrin inhibits the reaction [Camptothecin promotes the reaction [TP53 protein binds to CREBBP protein]]; pifithrin inhibits the reaction [Camptothecin results in increased activity of TP53 protein] TP53 protein results in increased susceptibility to Camptothecin Camptothecin results in decreased acetylation of TP53 protein TRP53 protein affects the susceptibility to Camptothecin TP53 mutant form results in decreased susceptibility to Camptothecin; TP53 protein mutant form results in decreased susceptibility to Camptothecin; TP53 protein results in decreased susceptibility to Camptothecin
CTD
PMID:9673414 PMID:10692111 PMID:11279278 PMID:11741290 PMID:12082016 PMID:13679428 PMID:17555331 PMID:19481069 PMID:20477944 PMID:20978201 PMID:23285096 PMID:24726431 PMID:25269479 PMID:26657896 More...
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tp53i11
tumor protein p53 inducible protein 11
increases expression
ISO
Camptothecin results in increased expression of TP53I11 mRNA
CTD
PMID:38460933
NCBI chr 3:79,144,824...79,160,056
Ensembl chr 3:79,144,895...79,160,050
G
Tp53i3
tumor protein p53 inducible protein 3
increases expression
ISO
Camptothecin results in increased expression of TP53I3 mRNA
CTD
PMID:17374387
NCBI chr 6:27,818,327...27,825,753
G
Tp53inp1
tumor protein p53 inducible nuclear protein 1
increases expression
ISO
Camptothecin results in increased expression of TP53INP1 mRNA
CTD
PMID:38460933
NCBI chr 5:24,253,986...24,272,250
Ensembl chr 5:24,260,568...24,267,968
G
Tp53inp2
tumor protein p53 inducible nuclear protein 2
increases expression
ISO
Camptothecin results in increased expression of TP53INP2 mRNA
CTD
PMID:38460933
NCBI chr 3:143,881,427...143,890,104
Ensembl chr 3:143,882,021...143,890,097
G
Tp63
tumor protein p63
decreases expression
ISO
Camptothecin results in decreased expression of TP63 protein alternative form
CTD
PMID:23376119
NCBI chr11:74,838,858...75,049,764
Ensembl chr11:74,838,859...75,049,398
G
Traf6
TNF receptor associated factor 6
decreases response to substance
ISO
TRAF6 mRNA results in decreased susceptibility to Camptothecin
CTD
PMID:25269479
NCBI chr 3:87,963,517...87,988,316
Ensembl chr 3:87,963,514...87,983,507
G
Trank1
tetratricopeptide repeat and ankyrin repeat containing 1
increases expression
ISO
Camptothecin results in increased expression of TRANK1 mRNA
CTD
PMID:38460933
NCBI chr 8:111,275,973...111,355,491
Ensembl chr 8:111,276,354...111,355,092
G
Trim28
tripartite motif-containing 28
increases expression
ISO
Camptothecin results in increased expression of TRIM28 protein modified form
CTD
PMID:25977998
NCBI chr 1:73,652,441...73,659,388
Ensembl chr 1:73,652,709...73,659,380
G
Trim29
tripartite motif-containing 29
increases expression
ISO
Camptothecin results in increased expression of TRIM29 mRNA
CTD
PMID:38460933
NCBI chr 8:43,682,221...43,706,992
Ensembl chr 8:43,682,221...43,706,992
G
Trim3
tripartite motif-containing 3
increases expression
ISO
Camptothecin results in increased expression of TRIM3 mRNA
CTD
PMID:38460933
NCBI chr 1:159,950,921...159,973,600
Ensembl chr 1:159,944,908...159,973,600
G
Trim31
tripartite motif-containing 31
increases expression
ISO
Camptothecin results in increased expression of TRIM31 mRNA
CTD
PMID:38460933
NCBI chr20:1,653,165...1,666,494
Ensembl chr20:1,653,165...1,666,494
G
Trim67
tripartite motif-containing 67
increases expression
ISO
Camptothecin results in increased expression of TRIM67 mRNA
CTD
PMID:38460933
NCBI chr19:52,763,991...52,805,906
Ensembl chr19:52,764,387...52,800,422
G
Trim8
tripartite motif-containing 8
increases expression
ISO
Camptothecin results in increased expression of TRIM8 mRNA
CTD
PMID:38460933
NCBI chr 1:245,369,632...245,384,513
Ensembl chr 1:245,369,632...245,384,513
G
Tro
trophinin
increases expression
ISO
Camptothecin results in increased expression of TRO mRNA
CTD
PMID:38460933
NCBI chr X:19,563,395...19,574,507
Ensembl chr X:19,563,517...19,572,953
G
Tsg101
tumor susceptibility 101
decreases response to substance
ISO
TSG101 mRNA results in decreased susceptibility to Camptothecin
CTD
PMID:25269479
NCBI chr 1:97,412,689...97,442,589
Ensembl chr 1:97,410,848...97,442,554
G
Tspan1
tetraspanin 1
increases expression
ISO
Camptothecin results in increased expression of TSPAN1 mRNA
CTD
PMID:38460933
NCBI chr 5:129,646,139...129,659,383
Ensembl chr 5:129,646,993...129,652,017
G
Tspan12
tetraspanin 12
increases expression
ISO
Camptothecin results in increased expression of TSPAN12 mRNA
CTD
PMID:38460933
NCBI chr 4:50,313,768...50,389,246
Ensembl chr 4:50,313,772...50,389,246
G
Tulp4
TUB like protein 4
decreases expression
ISO
Camptothecin results in decreased expression of TULP4 mRNA
CTD
PMID:33770205
NCBI chr 1:46,682,416...46,813,167
Ensembl chr 1:46,682,863...46,809,688
G
Twf1
twinfilin actin-binding protein 1
decreases response to substance
ISO
TWF1 mRNA results in decreased susceptibility to Camptothecin
CTD
PMID:25269479
NCBI chr 7:125,715,938...125,727,834
Ensembl chr 7:125,716,015...125,727,894
G
Tyms
thymidylate synthetase
increases expression
ISO
Camptothecin results in increased expression of TYMS mRNA
CTD
PMID:16568373
NCBI chr 9:113,313,454...113,329,551
Ensembl chr 9:113,313,452...113,329,536
G
Tysnd1
trypsin like peroxisomal matrix peptidase 1
increases expression
ISO
Camptothecin results in increased expression of TYSND1 mRNA
CTD
PMID:38460933
NCBI chr20:29,637,942...29,646,492
Ensembl chr20:29,638,277...29,643,995
G
Uap1l1
UDP-N-acetylglucosamine pyrophosphorylase 1 like 1
increases expression
ISO
Camptothecin results in increased expression of UAP1L1 mRNA
CTD
PMID:38460933
NCBI chr 3:8,172,335...8,180,505
Ensembl chr 3:8,173,216...8,180,443
G
Ugt1a6
UDP glucuronosyltransferase family 1 member A6
decreases methylation
ISO
Camptothecin results in decreased methylation of UGT1A6 gene
CTD
PMID:30720231
NCBI chr 9:88,747,213...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Unc5b
unc-5 netrin receptor B
increases expression
ISO
Camptothecin results in increased expression of UNC5B mRNA
CTD
PMID:38460933
NCBI chr20:28,697,726...28,764,474
Ensembl chr20:28,697,726...28,764,537
G
Upf1
UPF1, RNA helicase and ATPase
decreases response to substance
ISO
UPF1 mRNA results in decreased susceptibility to Camptothecin
CTD
PMID:25269479
NCBI chr16:19,076,594...19,097,365
Ensembl chr16:19,076,322...19,096,568
G
Usp5
ubiquitin specific peptidase 5
decreases response to substance
ISO
USP5 mRNA results in decreased susceptibility to Camptothecin
CTD
PMID:25269479
NCBI chr 4:157,619,663...157,634,681
Ensembl chr 4:157,619,643...157,634,711
G
Vamp8
vesicle-associated membrane protein 8
increases expression
ISO
Camptothecin results in increased expression of VAMP8 mRNA
CTD
PMID:38460933
NCBI chr 4:104,442,383...104,452,884
Ensembl chr 4:104,442,393...104,452,897
G
Vangl2
VANGL planar cell polarity protein 2
increases expression
ISO
Camptothecin results in increased expression of VANGL2 mRNA
CTD
PMID:38460933
NCBI chr13:84,462,731...84,489,404
Ensembl chr13:84,465,527...84,489,378
G
Vegfa
vascular endothelial growth factor A
decreases expression decreases response to substance
ISO
Camptothecin results in decreased expression of VEGFA protein VEGFA protein results in decreased susceptibility to Camptothecin
CTD
PMID:16356833 PMID:20116850
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Vmo1
vitelline membrane outer layer 1 homolog
increases expression
ISO
Camptothecin results in increased expression of VMO1 mRNA
CTD
PMID:38460933
NCBI chr10:55,227,944...55,234,794
Ensembl chr10:55,227,944...55,229,289
G
Vpreb3
V-set pre-B cell surrogate light chain 3
increases expression
ISO
Camptothecin results in increased expression of VPREB3 mRNA
CTD
PMID:38460933
NCBI chr20:12,717,421...12,718,785
Ensembl chr20:12,716,779...12,719,520
G
Vps37d
VPS37D subunit of ESCRT-I
increases expression
ISO
Camptothecin results in increased expression of VPS37D mRNA
CTD
PMID:38460933
NCBI chr12:21,609,210...21,614,669
Ensembl chr12:21,609,182...21,614,659
G
Vsig1
V-set and immunoglobulin domain containing 1
increases expression
ISO
Camptothecin results in increased expression of VSIG1 mRNA
CTD
PMID:38460933
NCBI chr X:104,607,031...104,640,128
Ensembl chr X:104,607,031...104,639,249
G
Wfdc2
WAP four-disulfide core domain 2
increases expression
ISO
Camptothecin results in increased expression of WFDC2 mRNA
CTD
PMID:38460933
NCBI chr 3:153,286,946...153,314,832
Ensembl chr 3:153,286,131...153,292,807
G
Wnt4
Wnt family member 4
increases expression
ISO
Camptothecin results in increased expression of WNT4 mRNA
CTD
PMID:38460933
NCBI chr 5:149,513,573...149,535,415
Ensembl chr 5:149,514,018...149,532,859
G
Xiap
X-linked inhibitor of apoptosis
multiple interactions decreases response to substance
ISO
[Butyrates co-treated with Camptothecin] results in decreased expression of XIAP protein; [Camptothecin co-treated with FAS protein] results in decreased expression of XIAP protein XIAP protein results in decreased susceptibility to Camptothecin Camptothecin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of XIAP protein]
CTD
PMID:16061681 PMID:16211302 PMID:19633536 PMID:25449198
NCBI chr X:120,890,537...120,938,413
Ensembl chr X:120,897,907...120,934,700
G
Xrcc1
X-ray repair cross complementing 1
affects response to substance multiple interactions
ISO
XRCC1 protein affects the susceptibility to Camptothecin [XRCC1 protein affects the susceptibility to Camptothecin] which affects the abundance of NAD; olaparib affects the reaction [[XRCC1 protein affects the susceptibility to Camptothecin] which affects the abundance of NAD]; veliparib affects the reaction [[XRCC1 protein affects the susceptibility to Camptothecin] which affects the abundance of NAD]; XRCC1 protein affects the reaction [PARP1 protein affects the susceptibility to Camptothecin]
CTD
PMID:35778544
NCBI chr 1:80,140,495...80,168,705
Ensembl chr 1:80,141,207...80,168,701
G
Xrcc3
X-ray repair cross complementing 3
decreases expression
ISO
Camptothecin results in decreased expression of XRCC3 mRNA
CTD
PMID:24792648
NCBI chr 6:130,863,405...130,873,765
Ensembl chr 6:130,863,959...130,872,444
G
Xrcc4
X-ray repair cross complementing 4
decreases response to substance increases methylation
ISO
XRCC4 results in decreased susceptibility to Camptothecin Camptothecin results in increased methylation of XRCC4 gene
CTD
PMID:21785230 PMID:30720231
NCBI chr 2:20,948,464...21,197,705
Ensembl chr 2:20,951,200...21,197,808
G
Yars2
tyrosyl-tRNA synthetase 2
increases expression
ISO
Camptothecin results in increased expression of YARS2 mRNA
CTD
PMID:33770205
NCBI chr11:84,632,350...84,638,138
Ensembl chr11:84,624,369...84,638,125
G
Ypel3
yippee-like 3
increases expression
ISO
Camptothecin results in increased expression of YPEL3 mRNA
CTD
PMID:38460933
NCBI chr 1:181,384,385...181,387,706
Ensembl chr 1:181,384,357...181,387,705
G
Zap70
zeta chain of T cell receptor associated protein kinase 70
decreases response to substance
ISO
ZAP70 mRNA results in decreased susceptibility to Camptothecin
CTD
PMID:25269479
NCBI chr 9:38,989,750...39,011,701
Ensembl chr 9:38,989,750...39,011,700
G
Zc3hc1
zinc finger, C3HC-type containing 1
decreases response to substance
ISO
ZC3HC1 mRNA results in decreased susceptibility to Camptothecin
CTD
PMID:25269479
NCBI chr 4:58,989,989...59,011,925
Ensembl chr 4:58,989,987...59,011,933
G
Zfp282
zinc finger protein 282
increases expression
ISO
Camptothecin results in increased expression of ZNF282 mRNA
CTD
PMID:33770205
NCBI chr 4:76,884,996...76,910,250
Ensembl chr 4:76,884,924...76,911,370
G
Zfp35
zinc finger protein 35
increases expression
ISO
Camptothecin results in increased expression of ZNF79 mRNA
CTD
PMID:38460933
NCBI chr18:15,268,852...15,284,334
Ensembl chr18:15,268,814...15,285,088
G
Zfp385a
zinc finger protein 385A
increases expression
ISO
Camptothecin results in increased expression of ZNF385A mRNA
CTD
PMID:38460933
NCBI chr 7:134,448,914...134,475,548
Ensembl chr 7:134,448,921...134,475,548
G
Zfp398
zinc finger protein 398
increases expression
ISO
Camptothecin results in increased expression of ZNF398 mRNA
CTD
PMID:38460933
NCBI chr 4:76,849,672...76,881,075
Ensembl chr 4:76,849,681...76,876,243
G
Zfyve1
zinc finger FYVE-type containing 1
increases expression
ISO
Camptothecin results in increased expression of ZFYVE1 mRNA
CTD
PMID:38460933
NCBI chr 6:103,184,938...103,234,111
Ensembl chr 6:103,184,938...103,234,039
G
Zg16b
zymogen granule protein 16B
increases expression
ISO
Camptothecin results in increased expression of ZG16B mRNA
CTD
PMID:38460933
NCBI chr10:12,970,888...12,984,170
Ensembl chr10:12,979,020...12,983,572
G
Zmat3
zinc finger, matrin type 3
increases expression
ISO
Camptothecin results in increased expression of ZMAT3 mRNA
CTD
PMID:38460933
NCBI chr 2:115,106,046...115,136,888
Ensembl chr 2:115,106,966...115,136,863
G
Znrd2
zinc ribbon domain containing 2
increases expression
ISO
Camptothecin results in increased expression of SSSCA1 mRNA
CTD
PMID:38460933
NCBI chr 1:203,017,682...203,019,465
Ensembl chr 1:203,017,682...203,019,465
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all